epigenetics in cancer carcinogenesis 2009
TRANSCRIPT
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 1/56
. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]© The Author 2009
1
Epigenetics in Cancer
Shikhar Sharma1, 2, Theresa K. Kelly1 and Peter A. Jones1*
1Department of Urology, io!hemistry and "ole!#lar iology, 2 Department of $eneti!s,
"ole!#lar and %ell#lar iology, US%&'orris %omprehensi(e %an!er %enter Ke!k S!hool
of "edi!ine, Uni(ersity of So#thern %alifornia, )os Angeles, %A++-11, USA
#nning title/ 0pigeneti!s in %an!er
Keyords/ 0pigeneti!s, %an!er, D'A methylation, istone "odifi!ations, '#!leosome
Positioning, mi!ro'As
*To hom !orresponden!e sho#ld 3e addressed/ 0-mail/4ones5p6!!nt.#s!.ed#
Carcinogenesis Advance Access published September 13, 2009
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 2/56
2
ABSTRACT
0pigeneti! me!hanisms are essential for normal de(elopment and maintenan!e of
tiss#e spe!ifi! gene e7pression patterns in mammals. Disr#ption of epigeneti! pro!esses
!an lead to altered gene f#n!tion and malignant !ell#lar transformation. $lo3al !hanges
in the epigeneti! lands!ape are a hallmark of !an!er. The initiation and progression of
!an!er, traditionally seen as a geneti! disease, is no reali8ed to in(ol(e epigeneti!
a3normalities along ith geneti! alterations. e!ent ad(an!ements in the rapidly
e(ol(ing field of !an!er epigeneti!s ha(e shon e7tensi(e reprogramming of e(ery
!omponent of the epigeneti! ma!hinery in !an!er in!l#ding D'A methylation, histone
modifi!ations, n#!leosome positioning and non-!oding 'As, spe!ifi!ally mi!ro'A
e7pression. The re(ersi3le nat#re of epigeneti! a3errations has led to the emergen!e of
the promising field of epigeneti! therapy, hi!h is already making progress ith the
re!ent 9DA appro(al of three epigeneti! dr#gs for !an!er treatment. :n this re(ie, e
dis!#ss the !#rrent #nderstanding of alterations in the epigeneti! lands!ape that o!!#r in
!an!er !ompared to normal !ells, the roles of these !hanges in !an!er initiation and
progression, in!l#ding the !an!er stem !ell model, and the potential #se of this
knoledge in designing more effe!ti(e treatment strategies.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 3/56
;
INTRODUCTION
%hromatin str#!t#re defines the state in hi!h geneti! information in the form of
D'A is organi8ed ithin a !ell. This organi8ation of the genome into a pre!ise !ompa!t
str#!t#re greatly infl#en!es the a3ilities of genes to 3e a!ti(ated or silen!ed. 0pigeneti!s,
originally defined 3y %. . <addington as =the !a#sal intera!tions 3eteen genes and
their prod#!ts, hi!h 3ring the phenotype into 3eing> ?1@, in(ol(es #nderstanding
!hromatin str#!t#re and its impa!t on gene f#n!tion. <addingtons definition initially
referred to the role of epigeneti!s in em3ryoni! de(elopment, hoe(er, the definition of
epigeneti!s has e(ol(ed o(er time as it is impli!ated in a ide (ariety of 3iologi!al
pro!esses. The !#rrent definition of epigeneti!s is =the st#dy of herita3le !hanges in gene
e7pression that o!!#r independent of !hanges in the primary D'A seB#en!e.> "ost of
these herita3le !hanges are esta3lished d#ring differentiation and are sta3ly maintained
thro#gh m#ltiple !y!les of !ell di(ision, ena3ling !ells to ha(e distin!t identities hile
!ontaining the same geneti! information. This herita3ility of gene e7pression patterns is
mediated 3y epigeneti! modifi!ations, hi!h in!l#de methylation of !ytosine 3ases in
D'A, post-translational modifi!ations of histone proteins as ell as the positioning of
n#!leosomes along the D'A. The !omplement of these modifi!ations, !olle!ti(ely
referred to as the epigenome, pro(ides a me!hanism for !ell#lar di(ersity 3y reg#lating
hat geneti! information !an 3e a!!essed 3y !ell#lar ma!hinery. 9ail#re of the proper
maintenan!e of herita3le epigeneti! marks !an res#lt in inappropriate a!ti(ation or
inhi3ition of (ario#s signaling pathays and lead to disease states s#!h as !an!er ?2,;@.
e!ent ad(an!es in the field of epigeneti!s ha(e shon that h#man !an!er !ells
har3or glo3al epigeneti! a3normalities, in addition to n#mero#s geneti! alterations ?;,C@.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 4/56
C
These geneti! and epigeneti! alterations intera!t at all stages of !an!er de(elopment,
orking together to promote !an!er progression ?@. The geneti! origin of !an!er is
idely a!!epted, hoe(er re!ent st#dies s#ggest that epigeneti! alterations may 3e the
key initiating e(ents in some forms of !an!er ?E@. These findings ha(e led to a glo3al
initiati(e to #nderstand the role of epigeneti!s in the initiation and propagation of !an!er
?F@. The fa!t that epigeneti! a3errations, #nlike geneti! m#tations, are potentially
re(ersi3le and !an 3e restored to their normal state 3y epigeneti! therapy makes s#!h
initiati(es promising and therape#ti!ally rele(ant ?@.
:n this re(ie e take a !omprehensi(e look at the !#rrent #nderstanding of the
epigeneti! me!hanisms at ork in normal mammalian !ells and their !omparati(e
a3errations that o!!#r d#ring !ar!inogenesis. <e also dis!#ss the idea of !an!er stem
!ells as the originators of !an!er and the prospe!t of epigeneti! therapy in designing
effi!ient strategies for !an!er treatment.
EPIGENETIC MECHANISMS IN NORMAL CELLS
%hromatin is made of repeating #nits of n#!leosomes, hi!h !onsist of G1CE 3ase
pairs of D'A rapped aro#nd an o!tamer of fo#r !ore histone proteins H;, C, 2A
and 2I ?@. 0pigeneti! me!hanisms that modify !hromatin str#!t#re !an 3e di(ided
into fo#r main !ategories/ D'A methylation, !o(alent histone modifi!ations, non-
!o(alent me!hanisms s#!h as in!orporation of histone (ariants and n#!leosome
remodeling and non-!oding 'As in!l#ding mi!ro'As. These modifi!ations ork
together to reg#late the f#n!tioning of the genome 3y altering the lo!al str#!t#ral
dynami!s of !hromatin, primarily reg#lating its a!!essi3ility and !ompa!tness. The
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 5/56
interplay of these modifi!ations !reates an =epigeneti! lands!ape> hi!h reg#lates the
ay the mammalian genome manifests itself in different !ell types, de(elopmental stages
and disease states, in!l#ding !an!er ?C,1+-1C@. The distin!t patterns of these modifi!ations
present in different !ell#lar states ser(e as a g#ardian of !ell#lar identity HTa3le :I. ere
e ill dis!#ss the important aspe!ts of the key epigeneti! me!hanisms present in normal
!ells.
DNA Methylatin
D'A methylation is perhaps the most e7tensi(ely st#died epigeneti! modifi!ation
in mammals. :t pro(ides a sta3le gene silen!ing me!hanism hi!h plays an important role
in reg#lating gene e7pression and !hromatin ar!hite!t#re, in asso!iation ith histone
modifi!ations and other !hromatin asso!iated proteins. :n mammals, D'A methylation
primarily o!!#rs 3y the !o(alent modifi!ation of !ytosine resid#es in %p$ din#!leotides.
%p$ din#!leotides are not e(enly distri3#ted a!ross the h#man genome 3#t are instead
!on!entrated in short %p$-ri!h D'A stret!hes !alled =%p$ islands> and regions of large
repetiti(e seB#en!es He.g. !entromeri! repeats, retrotransposon elements, rD'A et!.I
?1,1E@. %p$ islands are preferentially lo!ated at the end of genes and o!!#py GE+ of
h#man gene promoters ?1F@. <hile most of the %p$ sites in the genome are methylated,
the ma4ority of %p$ islands #s#ally remain #nmethylated d#ring de(elopment and in
differentiated tiss#es ?11@. oe(er, some %p$ island promoters 3e!ome methylated
d#ring de(elopment, hi!h res#lts in long-term trans!riptional silen!ing. -!hromosome
ina!ti(ation and imprinted genes are !lassi! e7amples of s#!h nat#rally o!!#rring %p$
island methylation d#ring de(elopment ?1@. Some tiss#e-spe!ifi! %p$ island
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 6/56
E
methylation has also 3een reported to o!!#r in a (ariety of somati! tiss#es, primarily at
de(elopmentally important genes ?1,1@. :n !ontrast, the repetiti(e genomi! seB#en!es
that are s!attered all o(er the h#man genome are hea(ily methylated hi!h pre(ents
!hromosomal insta3ility 3y silen!ing non-!oding D'A and transposa3le D'A elements
?11@. D'A methylation !an lead to gene silen!ing 3y either pre(enting or promoting the
re!r#itment of reg#latory proteins to D'A. 9or e7ample, :t !an inhi3it trans!riptional
a!ti(ation 3y 3lo!king trans!ription fa!tors from a!!essing target 3inding sites e.g. !-my!
and ")T9 ?2+,21@. Alternati(ely, it !an pro(ide 3inding sites for methyl-3inding domain
H"DI proteins, hi!h !an mediate gene repression thro#gh intera!tions ith histone
dea!etylases HDA%sI ?22,2;@. Th#s, D'A methylation #ses a (ariety of me!hanisms to
herita3ly silen!e genes and non-!oding genomi! regions.
The pre!ise D'A methylation patterns fo#nd in the mammalian genome are
generated and herita3ly maintained 3y the !ooperati(e a!ti(ity of the de novo
methyltransferases - D'"T;A and D'"T;, hi!h a!t independent of repli!ation and
sho eB#al preferen!e for 3oth #nmethylated and hemimethylated D'A and the
maintenan!e D'A methyltransferases - D'"T1, hi!h a!ts d#ring repli!ation
preferentially methylating hemimethylated D'A ?2C,2@.
<hile the role of %p$ island promoter methylation in gene silen!ing is ell
esta3lished, m#!h less is knon a3o#t the role of methylation of non-%p$ island
promoters. e!ent st#dies ha(e shon that D'A methylation is also important for the
reg#lation of non-%p$ island promoters. 9or e7ample, tiss#e-spe!ifi! e7pression of
"ASP:', hi!h does not !ontain a %p$ island ithin its promoter, is reg#lated 3y D'A
methylation ?2E@. Similarly, methylation of the non-%p$ island L!t-C promoter, strongly
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 7/56
F
infl#en!es its e7pression le(el ?2F@. Sin!e %p$ islands o!!#py only GE+ of h#man gene
promoters, it is essential to el#!idate the role of non-%p$ island methylation in order to
f#lly #nderstand the glo3al role of D'A methylation in normal tiss#e ?1F@.
C!alent Histne M"i#icatins
istone proteins, hi!h !omprise the n#!leosome !ore, !ontain a glo3#lar %-
terminal domain and an #nstr#!t#red '-terminal tail ?@. The amino terminal tails of
n#!leosomes !an #ndergo a (ariety of post-translational !o(alent modifi!ations in!l#ding
methylation, a!etylation, #3iB#itylation, s#moylation, and phosphorylation on spe!ifi!
resid#es ?12@. These modifi!ations reg#late key !ell#lar pro!esses s#!h as trans!ription,
repli!ation and repair ?12@. The !omplement of modifi!ations is proposed to store the
epigeneti! memory inside a !ell in the form of a =histone !ode> hi!h determines the
str#!t#re and a!ti(ity of different !hromatin regions ?2@. istone modifi!ations ork 3y
either !hanging the a!!essi3ility of !hromatin or 3y re!r#iting and&or o!!l#ding non-
histone effe!tor proteins, hi!h de!ode the message en!oded 3y the modifi!ation
patterns. The me!hanism of inheritan!e of this =histone !ode> hoe(er, is still not f#lly
#nderstood.
Unlike D'A methylation, histone modifi!ations !an lead to either a!ti(ation or
repression depending #pon hi!h resid#es are modified and the type of modifi!ations
present. 9or e7ample, lysine a!etylation !orrelates ith trans!riptional a!ti(ation ?12,2@
hile lysine methylation leads to trans!riptional a!ti(ation or repression depending #pon
hi!h resid#e is modified and the degree of methylation. 9or e7ample, trimethylation of
lysine C on histone ; H;KCme;I is enri!hed at trans!riptionally a!ti(e gene promoters
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 8/56
?;+@ hile trimethylation of ;K H;Kme;I and ;K2F H;K2Fme;I is present at
gene promoters that are trans!riptionally repressed ?12@. These to modifi!ations
together !onstit#te the to main silen!ing me!hanisms in mammalian !ells, ;Kme;
orking in !on!ert ith D'A methylation and ;K2Fme; largely orking e7!l#si(e of
D'A methylation H9ig#re 1I. A (ast array of a!ti(e and repressi(e histone modifi!ations
ha(e 3een identified, hi!h !onstit#te a !omple7 gene reg#latory netork essential for
the physiologi! a!ti(ities of !ells ?1+,12@. $enome-ide st#dies shoing distin!t
lo!ali8ation and !om3inatorial patterns of these histone marks in the genome ha(e
signifi!antly in!reased o#r #nderstanding of ho these di(erse modifi!ations a!t in a
!ooperati(e manner to reg#late glo3al gene e7pression patterns ?;1,;2@.
Spe!ifi! patterns of histone modifi!ations are present ithin distin!t !ell types
and are proposed to play a key role in determining !ell#lar identity ?;;,;C@. 9or e7ample,
em3ryoni! stem H0SI !ells possess =3i(alent domains> hi!h !ontain !oe7isting a!ti(e
H;KCme;I and repressi(e H;K2Fme;I marks at promoters of de(elopmentally
important genes ?;,;E@. S#!h 3i(alent domains are esta3lished 3y the a!ti(ity of to
!riti!al reg#lators of de(elopment in mammals/ the poly!om3 gro#p HP!$I hi!h
!ataly8es the repressi(e ;K2F trimethylation mark and is essential for maintaining 0S
!ell pl#ripoten!y thro#gh silen!ing !ell-fate spe!ifi! genesM and potentially the trithora7
gro#p Htr7$I hi!h !ataly8es the a!ti(ating ;KC trimethylation mark and is reB#ired for
maintaining a!ti(e !hromatin states d#ring de(elopment ?;C@. This 3i(alen!y is
hypothesi8ed to add to phenotypi! plasti!ity, ena3ling 0S !ells to tightly reg#late gene
e7pression d#ring different de(elopmental pro!esses. Differentiated !ells lose this
3i(alen!y and a!B#ire a more rigid !hromatin str#!t#re, hi!h may 3e important for
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 9/56
maintaining !ell fate d#ring !ell#lar e7pansion ?;;@. This hypothesis is s#pported 3y the
re!ent dis!o(ery of large !ondensed !hromatin regions !ontaining the repressi(e
;Kme2 mark, termed =)L%Ks> Hlarge organi8ed !hromatin K modifi!ationsI, in
differentiated 0S !ells hi!h !an maintain silen!ing of large genomi! regions in
differentiated tiss#es ?;F@.
istone modifi!ation patterns are dynami!ally reg#lated 3y en8ymes that add and
remo(e !o(alent modifi!ations to histone proteins. istone a!etyltransferases HATsI
and histone methyltransferases H"TsI, add a!etyl and methyl gro#ps, respe!ti(ely hile
histone dea!etylases HDA%sI and histone demethylases HD"sI remo(e a!etyl and
methyl gro#ps, respe!ti(ely ?;,;@. A n#m3er of histone modifying en8ymes in!l#ding
(ario#s ATs, "Ts, DA%s and D"s ha(e 3een identified in the past de!ade ?12@.
These histone modifying en8ymes intera!t ith ea!h other as ell as other D'A
reg#latory me!hanisms to tightly link !hromatin state and trans!ription.
Interplay # DNA Methylatin an" Histne M"i#icatins
:n addition to performing their indi(id#al roles, histone modifi!ations and D'A
methylation intera!t ith ea!h other at m#ltiple le(els, to determine gene e7pression
stat#s, !hromatin organi8ation and !ell#lar identity ?C+@. Se(eral histone
methyltransferases in!l#ding $a, SUN;1 and P"T, !an dire!t D'A methylation
to spe!ifi! genomi! targets 3y dire!tly re!r#iting D'"Ts to sta3ly silen!ed genes ?C1-
C;@. :n addition to the dire!t re!r#itment of D'"Ts, histone methyltransferases and
demethylases also infl#en!e D'A methylation le(els 3y reg#lating the sta3ility of
D'"T proteins ?CC,C@. D'"Ts !an in t#rn re!r#it DA%s and methyl 3inding proteins
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 10/56
1+
H"PsI to a!hie(e gene silen!ing and !hromatin !ondensation ?22,2;@. D'A methylation
!an also dire!t ;K methylation thro#gh effe!tor proteins, s#!h as "e%P2, there3y
esta3lishing a repressi(e !hromatin state ?CE@. The intera!tions 3eteen D'A
methylation ma!hinery and histone modifying en8ymes f#rther enhan!e the !omple7ity
of epigeneti! reg#lation of gene e7pression, hi!h determines and maintains !ell#lar
identity and f#n!tion.
N$cles%e Psitining & Histne 'ariants
'on-!o(alent me!hanisms, s#!h as n#!leosome remodeling and repla!ement of
!anoni!al histone proteins ith spe!iali8ed histone (ariants, also play an important role in
ho !hromatin str#!t#re reg#lates gene a!ti(ity. :n addition to ser(ing as the 3asi!
mod#les for D'A pa!kaging ithin a !ell, n#!leosomes reg#late gene e7pression 3y
altering the a!!essi3ility of reg#latory D'A seB#en!es to trans!ription fa!tors ?1C@.
$enome-ide n#!leosome mapping data for (ario#s e#karyoti! organisms re(eal a
!ommon organi8ational theme ith pre!ise positioning of n#!leosomes aro#nd gene
promoters, !ompared to the relati(ely random pattern fo#nd in gene 3odies ?CF@.
'#!leosome 9ree egions H'9sI present at the and ; ends of genes are tho#ght to
pro(ide the sites for assem3ly and disassem3ly of the trans!ription ma!hinery ?C@. The
loss of a n#!leosome dire!tly #pstream of the TSS is tightly !orrelated ith gene
a!ti(ation ?C,+@. 9#rthermore, the presen!e of an '9 at gene promoters ith 3asal
le(el of trans!ription !orrelates ith their a3ility for rapid a!ti(ation #pon stim#lation
?1@. :n !ontrast, o!!l#sion of the trans!ription start site HTSSI ithin the '9 3y a
n#!leosome is asso!iated ith gene repression ?2@. "od#lation of the '9s is
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 11/56
11
or!hestrated 3y ATP-dependent !hromatin remodeling !omple7es, hi!h modify the
a!!essi3ility of D'A reg#latory sites thro#gh 3oth sliding and e4e!tion of n#!leosomes
?;@. The intera!tion of n#!leosome remodeling ma!hinery ith D'A methylation and
histone modifi!ations plays a pi(otal role in esta3lishing glo3al gene e7pression patterns
and !hromatin ar!hite!t#re H9ig#re 1 and 2I ?C,@.
:n addition to physi!al alterations in n#!leosomal positioning (ia n#!leosome
remodelers, the in!orporation of histone (ariants e.g. ;.; and 2A.O, into n#!leosomes
also infl#en!es n#!leosome o!!#pan!y and th#s gene a!ti(ity ?E,F@. Unlike the ma4or
histone s#3types hose synthesis and in!orporation is !o#pled to D'A repli!ation in S
phase, these (ariants are synthesi8ed and in!orporated into !hromatin thro#gho#t the !ell
!y!le ?E@. ;.; and 2A.O are preferentially enri!hed at promoters of a!ti(e genes or
genes poised for a!ti(ation and !an mediate gene a!ti(ation 3y altering the sta3ility of
n#!leosomes ?@. 2A.O in!orporation may also !ontri3#te to gene a!ti(ation 3y
prote!ting genes against D'A methylation ?@. :n 0S !ells, 2A.O !o-lo!ali8es ith
3i(alent domains here it may assist in maintaining key de(elopmental genes in a poised
state ?E+@. )ike !anoni!al histones, histone (ariants #ndergo (ario#s post-translational
modifi!ations, hi!h determine their n#!lear lo!ali8ation and f#n!tion. 9or e7ample,
a!etylated 2A.O primarily asso!iates ith a!ti(e genes in e#!hromatin hile
#3iB#itylated 2A.O asso!iates ith fa!#ltati(e hetero!hromatin ?E1,E2@. Taken together,
the in!l#sion of histone (ariants ithin n#!leosomes pro(ides an additional epigeneti!
me!hanism #tili8ed 3y !ells to modify !hromatin str#!t#re a!!ording to the needs of
di(erse !ell#lar pro!esses.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 12/56
12
%iRNAs
"i!ro'As Hmi'AsI are small, G22 n#!leotide, non-!oding 'As that reg#late
gene e7pression thro#gh post-trans!riptional silen!ing of target genes. SeB#en!e-spe!ifi!
3ase pairing of mi'As ith ; #ntranslated regions of target m'A ithin the :S%
!omple7 H'A-ind#!ed silen!ing !omple7I res#lts in target m'A degradation or
inhi3ition of translation ?E;@. mi'As are e7pressed in a tiss#e spe!ifi! manner and
!ontrol a ide array of 3iologi!al pro!esses in!l#ding !ell proliferation, apoptosis and
differentiation. The list of mi'As identified in the h#man genome and their potential
target genes is groing rapidly, demonstrating their e7tensi(e role in maintaining glo3al
gene e7pression patterns ?1;@. )ike normal genes, the e7pression of mi'As !an 3e
reg#lated 3y epigeneti! me!hanisms ?EC@. :n addition, mi'As !an also mod#late
epigeneti! reg#latory me!hanisms inside a !ell 3y targeting en8ymes responsi3le for
D'A methylation HD'"T;A and D'"T;I and histone modifi!ations H0O2I ?E,EE@.
S#!h intera!tion among the (ario#s !omponents of the epigeneti! ma!hinery re-
emphasi8es the integrated nat#re of epigeneti! me!hanisms in(ol(ed in the maintenan!e
of glo3al gene e7pression patterns.
ABERRANT REPROGRAMMING O( THE EPIGENOME IN CANCER
The pre!ise epigenomi! lands!ape present in normal !ells #ndergoes e7tensi(e
distortion in !an!er ?C@. These epim#tations, along ith idespread geneti! alterations,
play an important role in !an!er initiation and progression ?;@. The !an!er epigenome is
!hara!teri8ed 3y glo3al !hanges in D'A methylation and histone modifi!ation patterns as
ell as altered e7pression profiles of !hromatin modifying en8ymes. These epigeneti!
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 13/56
1;
!hanges res#lt in glo3al dysreg#lation of gene e7pression profiles leading to the
de(elopment and progression of disease states ?2@. 0pim#tations !an lead to silen!ing of
t#mor s#ppressor genes independently and also in !on4#n!tion ith deleterio#s geneti!
m#tations or deletions, th#s ser(ing as the se!ond hit reB#ired for !an!er initiation
a!!ording to the =to-hit> model proposed 3y Alfred Kn#dson ?@. :n addition to
ina!ti(ating t#mor s#ppressors, epim#tations !an also promote t#morigenesis 3y
a!ti(ating on!ogenes. The e(ents that lead to initiation of these epigeneti! a3normalities
are still not f#lly #nderstood. 'e(ertheless, sin!e epigeneti! alterations, like geneti!
m#tations, are mitoti!ally herita3le, they are sele!ted for in a rapidly groing !an!er !ell
pop#lation and !onfer a groth ad(antage to t#mor !ells res#lting in their #n!ontrolled
groth.
DNA Methylatin A)erratins in Cancer
%an!er initiation and progression are a!!ompanied 3y profo#nd !hanges in D'A
methylation hi!h ere the first epigeneti! alterations identified in !an!er ?EF,E@. A
!an!er epigenome is marked 3y genome-ide hypomethylation and site-spe!ifi! %p$
island promoter hypermethylation H9ig#re 2I ?;@. <hile the #nderlying me!hanisms
hi!h initiate these glo3al !hanges are still #nder in(estigation, re!ent st#dies indi!ate
that some !hanges o!!#r (ery early in !an!er de(elopment and may !ontri3#te to !an!er
initiation ?E@.
$lo3al D'A hypomethylation plays a signifi!ant role in t#morigenesis and o!!#rs
at (ario#s genomi! seB#en!es in!l#ding repetiti(e elements, retrotransposons, %p$ poor
promoters, introns and gene deserts ?E@. D'A hypomethylation at repeat seB#en!es
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 14/56
1C
leads to in!reased genomi! insta3ility 3y promoting !hromosomal rearrangements ?;,F+@.
ypomethylation of retrotransposons !an res#lt in their a!ti(ation and translo!ation to
other genomi! regions, th#s in!reasing genomi! insta3ility ?F1@. :nd#!tion of genomi!
insta3ility 3y hypomethylation is 3est e7emplified in patients ith the :%9
Himm#nodefi!ien!y, !entromeri! region insta3ility and fa!ial anomaliesI syndrome,
hi!h ha(e a germ-line m#tation in the D'"T; en8yme res#lting in hypomethylation
and s#3seB#ent !hromosomal insta3ility ?F2@. Similar loss of D'A methylation and
genomi! insta3ility is impli!ated in a (ariety of h#man !an!ers ?F1@. :n addition, D'A
hypomethylation !an lead to the a!ti(ation of groth-promoting genes, s#!h as R-Ras
and MAPSIN in gastri! !an!er, S-100 in !olon !an!er and MAGE Hmelanoma-asso!iated
antigenI in melanoma ?F;@ and a loss of imprinting H)L:I in t#mors ?FC@. :n <ilms
t#mor, hypomethylation ind#!ed )L: of IGF2, an important a#to!rine groth fa!tor,
res#lts in its pathologi!al 3ialleli! e7pression ?F@. )L: of :$92 has also 3een linked ith
an in!reased risk of !olore!tal !an!er ?FE@. Th#s, D'A hypomethylation leads to a3errant
a!ti(ation of genes and non-!oding regions thro#gh a (ariety of me!hanisms hi!h
!ontri3#tes to !an!er de(elopment and progression.
:n !ontrast to hypomethylation, hi!h in!reases genomi! insta3ility and a!ti(ates
proto-on!ogenes, site-spe!ifi! hypermethylation !ontri3#tes to t#morigenesis 3y silen!ing
t#mor s#ppressor genes. Sin!e the initial dis!o(ery of %p$ island hypermethylation of
the Rb promoter Ha t#mor s#ppressor gene asso!iated ith retino3lastomaI ?FF@, (ario#s
other t#mor s#ppressor genes in!l#ding p16 , MLH1 and BRCA1, ha(e also 3een shon to
#ndergo t#mor-spe!ifi! silen!ing 3y hypermethylation ?;,C,F@. These genes are in(ol(ed
in !ell#lar pro!esses, hi!h are integral to !an!er de(elopment and progression,
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 15/56
1
in!l#ding D'A repair, !ell !y!le, !ell adhesion, apoptosis and angiogenesis. 0pigeneti!
silen!ing of s#!h t#mor s#ppressor genes !an also lead to t#mor initiation 3y ser(ing as
the se!ond hit in the Kn#dsons =to-hit> model ?@. :n addition to dire!t ina!ti(ation of
t#mor s#ppressor genes, D'A hypermethylation !an also indire!tly silen!e additional
!lasses of genes 3y silen!ing trans!ription fa!tors and D'A-repair genes. Promoter
hypermethylation ind#!ed silen!ing of trans!ription fa!tors s#!h as RUNX in esophageal
!an!er ?F@, and GA!A-" and GA!A-# in !olore!tal and gastri! !an!ers ?+@, leads to
ina!ti(ation of their donstream targets. Silen!ing of D'A-repair genes He.g. MLH1,
BRCA1 et!.I ena3les !ells to a!!#m#late f#rther geneti! lesions leading to the rapid
progression of !an!er.
<hile the a3ility of D'A hypermethylation to silen!e t#mor s#ppressor genes in
!an!er is ell esta3lished, ho genes are targeted for this a3errant D'A methylation is
still #n!lear. Lne possi3ility is that silen!ing spe!ifi! genes 3y hypermethylation pro(ides
a groth ad(antage to !ells res#lting in their !lonal sele!tion and proliferation. T#mor-
spe!ifi! %p$ island methylation !an o!!#r thro#gh a seB#en!e spe!ifi! instr#!ti(e
me!hanism 3y hi!h D'"Ts are targeted to spe!ifi! genes 3y their asso!iation ith
on!ogeni! trans!ription fa!tors. A3errant hypermethylation and silen!ing of spe!ifi!
target gene promoters 3y the P")-A f#sion protein in a!#te promyelo!yti! le#kemia
is an e7ample of s#!h a me!hanism ?1@. )arge stret!hes of D'A !an 3e!ome a3normally
methylated in !an!er ?2@ !a#sing some %p$ islands to 3e hypermethylated as a res#lt of
their lo!ation inside s#!h genomi! regions hi!h ha(e #ndergone large-s!ale epigeneti!
reprogramming. Another interesting me!hanism proposes a role of histone marks in the
t#mor-spe!ifi! targeting of de novo methylation and ill 3e dis!#ssed in detail in the ne7t
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 16/56
1E
se!tion. :nterestingly, regions that are hypermethylated in !an!er are often pre-marked
ith ;K2Fme; poly!om3 mark in em3ryoni! stem H0SI !ells H9ig#re ;I ?;-@
s#ggesting a link 3eteen the reg#lation of de(elopment and t#morigenesis. This
o3ser(ation also partially e7plains the theory of =%p$ island methylator phenotype> or
%:"P hi!h hypothesi8es that there is !oordinated methylation of a s#3set of %p$
islands in t#mors sin!e many of these %:"P lo!i are knon poly!om3 targets ?C,E@.
9#rther #nderstanding of ho spe!ifi! genomi! regions are targeted for D'A
hypermethylation in !an!er ill potentially lead to additional therape#ti! targets.
Changes in Histne M"i#icatins in Cancer
e!ent ad(an!es in high thro#ghp#t seB#en!ing ha(e ena3led genome ide
mapping of !hromatin !hanges o!!#rring d#ring t#morigenesis. These st#dies ha(e
re(ealed a glo3al loss of a!etylated C-lysine 1E HCK1Ea!I and C-lysine 2+
trimethylation HCK2+me;I ?F@. S#!h loss of histone a!etylation, hi!h is mediated 3y
histone dea!etylases HDA%sI res#lts in gene repression. DA%s are often fo#nd
o(ere7pressed in (ario#s types of !an!er ?,@ and th#s, ha(e 3e!ome a ma4or target for
epigeneti! therapy. istone a!etyltransferases HATsI, hi!h ork in !on!ert ith
DA%s to maintain histone a!etylation le(els, !an also 3e altered in !an!er. A3errant
formation of f#sion proteins thro#gh !hromosomal translo!ations of AT and AT-
related genes He.g. "LO, "L9, %P and p;++I o!!#rs in le#kemia ?+@. "istargeting
of s#!h deleterio#s f#sion proteins !ontri3#tes to glo3al alterations in histone a!etylation
patterns in !an!er.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 17/56
1F
:n addition to !hanges in histone a!etylation, !an!er !ells also display idespread
!hanges in histone methylation patterns. Alterations in ;K and ;K2F methylation
patterns are asso!iated ith a3errant gene silen!ing in (ario#s forms of !an!er ?1,2@.
Dysreg#lation of histone methyltransferases responsi3le for repressi(e marks res#lts in
altered distri3#tion of these marks in !an!er and leads to a3errant silen!ing of t#mor
s#ppressor genes. 9or e7ample, 0O2, hi!h is the ;K2F histone methyltransferase, is
o(ere7pressed in 3reast and prostate !an!er ?2@. :n!reased le(els of $a, the ;K
histone methyltransferase, has 3een fo#nd in li(er !an!er, and is impli!ated in
perpet#ating malignant phenotype possi3ly thro#gh mod#lation of !hromatin str#!t#re
?;,C@ . %hromosomal translo!ations of ")), the ;KC histone methyltransferase,
leads to e!topi! e7pression of (ario#s homeoti! Ho7I genes and plays a key role in
le#kemi! progression ?@.
:n addition to histone methyltransferases, lysine spe!ifi!-demethylases hi!h
ork in !oordination ith "Ts to maintain glo3al histone methylation patterns, are also
impli!ated in !an!er progression ?E@. )SD1, the first identified lysine-demethylase, !an
effe!ti(ely remo(e 3oth a!ti(ating and repressing marks H;KC and ;K methylation,
respe!ti(elyI depending on its spe!ifi! 3inding partners ?F,@, th#s, a!ting as either a
!o-repressor or a !o-a!ti(ator. After )SD1, se(eral other histone lysine demethylases
ha(e 3een dis!o(ered in!l#ding J#mon4i % domain HJm4%I proteins. Se(eral of these
histone demethylases are #preg#lated in prostate !an!er, th#s making them potential
therape#ti! targets ?;@. oe(er, sin!e histone demethylases, like )SD1, !an perform
3oth a!ti(ating and repressi(e f#n!tions, it is essential to first #nderstand their pre!ise
!onte7t-dependent roles 3efore their therape#ti! inhi3ition !an 3e #sed as an effe!ti(e
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 18/56
1
!an!er treatment strategy. Despite these !hallenges, targeting histone demethylases is a
promising treatment option for the f#t#re as re(ealed 3y a re!ent st#dy hi!h shoed that
inhi3ition of )SD1 in ne#ro3lastoma, !a#ses de!reased proliferation $n v$%&o and
inhi3ition of 7enograft groth ?@.
Epigenetic S*itching in Cancer
As mentioned pre(io#sly, D'A methylation and histone modifi!ations ork
independently and in !on!ert to alter gene e7pression d#ring t#morigenesis. A key fa!et
of s#!h silen!ing me!hanisms is the formation of a rigid repressi(e !hromatin state hi!h
res#lts in red#!ed !ell#lar plasti!ity. The re!ent dis!o(ery of t#mor-spe!ifi! de novo
methylation of poly!om3 target genes, hi!h are silen!ed 3y ;K2Fme; in normal !ells,
is another e7ample of this phenomenon ?;-@. :n 0S !ells, de(elopmentally important
genes are re(ersi3ly silen!ed 3y poly!om3 proteins thro#gh the esta3lishment of the
repressi(e ;K2Fme; mark. After differentiation, these genes !ontin#e to 3e repressed
thro#gh the maintenan!e of the poly!om3 mark on #nmethylated promoters 3y 0O2. :n
!an!er, the poly!om3 mark is repla!ed 3y de novo D'A methylation possi3ly thro#gh the
re!r#itment of D'"Ts (ia the poly!om3 !omple7 ?1++@. This t#mor-spe!ifi! =epigeneti!
sit!hing> of the plasti! poly!om3 mark ith more sta3le D'A methylation res#lts in
the permanent silen!ing of key reg#latory genes hi!h may !ontri3#te to !ell
proliferation and t#morigenesis H9ig#re ;I ?1+1@. oe(er, hi!h transformation-
asso!iated fa!tors trigger this sit!h is still #n!lear.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 19/56
1
Rle # N$cles%e Psitining in Cancer
The roles of D'A methylation and histone modifi!ations in !an!er initiation and
progression are ell esta3lished, hoe(er the !hanges in !hromatin str#!t#re that
a!!ompany D'A methylation and histone modifi!ation !hanges are less ell #nderstood.
0merging data has re(ealed that n#!leosome remodeling orks in !on!ert ith D'A
methylation and histone modifi!ations, and plays a !entral role in t#mor-spe!ifi! gene
silen!ing. D'A methylation ind#!ed silen!ing of t#mor s#ppressor genes in !an!er
in(ol(es distin!t !hanges in n#!leosome positioning res#lting in n#!leosome o!!#pan!y
at TSS H9ig#re 2I. ea!ti(ation of s#!h silen!ed genes #sing D'"T inhi3itors is
a!!ompanied 3y a loss of n#!leosomes from the promoter region ?+@. :n addition,
n#!leosome remodeling !an lead to a3errant gene silen!ing (ia the transmission of
repressi(e epigeneti! marks to t#mor s#ppressor gene promoters. e!ent ork 3y "orey
et al. H2++I demonstrated that n#!leosome remodeling and dea!etylase !orepressor
!omple7 H'#DI plays a !entral role in a3errant gene silen!ing in le#kemia (ia the
on!ogeni! trans!ription fa!tor, P")-Aa. The '#D !omple7 fa!ilitates re!r#itment
of the poly!om3 repressi(e !omple7 2 HP%2I and D'"T;A to P")-Aa target gene
promoters leading to their permanent silen!ing 3y esta3lishing a repressi(e !hromatin
state ?1+2@. '#D !an also 3e re!r#ited to methylated promoters thro#gh its intera!tion
ith the "D2 protein ?1+;@. S#stained 3inding of '#D to s#!h promoters may assist
in preser(ing their repressi(e state thro#gh maintenan!e of D'A methylation.
Alterations in the S<:&S'9 !omple7, an ATP-dependent !hromatin remodeling
!omple7, are also asso!iated ith !an!er de(elopment ?1+C@. A3rogation of S<:&S'9
f#n!tion thro#gh alterations in its (ario#s s#3#nits !an res#lt in malignant transformation.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 20/56
2+
The A9CF HhS'9I s#3#nit of the S<:&S'9 !omple7 is a bona '$de t#mor s#ppressor
and its inhi3ition in rha3doid t#mors !a#ses ina!ti(ation of the p21 and p1E pathays
leading to on!ogeni! transformation ?1+@. 9#rthermore, $1 and ", the !atalyti!
s#3#nits of S<:&S'9, are silen!ed in a3o#t 1-2+ of primary non-small-!ell l#ng
!an!ers ?1+E@. Treatment of " n#ll !ell lines ith DA% inhi3itors has 3een shon
to restore its e7pression th#s making it a promising target for epigeneti! therapy.
oe(er, s#!h treatment also res#lted in a!etylation of " protein hi!h a3rogated its
f#n!tion ?1+C@. De(elopment of spe!ifi! DA% inhi3itors, hi!h !an !ir!#m(ent "
a!etylation, is essential for s#!!essf#l ind#!tion of f#n!tional " in t#mors, hi!h !an
3e #sed as a prospe!ti(e therape#ti! target in the f#t#re.
:nterestingly, a !onte7t dependent on!ogeni! role of $1 has also 3een
proposed. <ork 3y 'aid# et al. H2++I re(eals that $1 !ontri3#tes to !an!er
de(elopment 3y !onstraining p; a!ti(ity thro#gh the desta3ili8ation of the p; protein.
Lpposing roles of S<:&S'9 s#3#nits highlights the reB#irement for a deeper
#nderstanding of the role of n#!leosome remodeling in !an!er de(elopment in order to
de(elop effe!ti(e t#mor-spe!ifi! therapies ?1+F@.
:n addition to remodeling !omple7es, the histone (ariant 2A.O has also 3een
impli!ated in t#morigenesis. 2A.O is o(ere7pressed in se(eral types of !an!er and has
3een asso!iated ith the promotion of !ell !y!le progression ?E2@. :nterestingly, loss of
2A.O has also 3een impli!ated in t#mor progression thro#gh possi3le desta3ili8ation of
!hromosomal 3o#ndaries res#lting in spreading of repressi(e !hromatin domains and de
novo hypermethylation of t#mor-s#ppressor gene promoters ?1+@.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 21/56
21
Dereg$latin # %iRNAs in Cancer
A!!#m#lating e(iden!e from st#dies !omparing mi'A e7pression profiles in
t#mors and !orresponding normal tiss#es indi!ate idespread !hanges in mi'A
e7pression d#ring t#morigenesis ?1+@. Sin!e mi'As reg#late genes in(ol(ed in
trans!riptional reg#lation, !ell proliferation and apoptosis Hthe most !ommon pro!esses
dereg#lated in !an!erI, alteration in their e7pression !an promote t#morigenesis. mi'As
!an f#n!tion as either t#mor s#ppressors or on!ogenes depending #pon their target genes.
"any t#mor s#ppressor mi'As that target groth promoting genes are repressed in
!an!er. 9or e7ample, ($R-1 and 16 hi!h target BCL2, an anti-apoptoti! gene, are
donreg#lated in !hroni! lympho!yti! le#kemia, hile )e% -F hi!h targets the on!ogene,
RAS* is donreg#lated in l#ng !an!er ?1;,11+@. 9#rthermore, ($R-12+ , hi!h targets
%)E, is signifi!antly donreg#lated in prostate and 3ladder t#mors ?111@ and ($&-101,
hi!h targets poly!om3 gro#p protein 0O2, is donreg#lated in 3ladder transitional
!ell !ar!inoma ?EE@. :n !ontrast to t#mor s#ppressor mi'As, on!ogeni! mi'As, hi!h
target groth inhi3itory pathays, are often #preg#lated in !an!er. 9or e7ample, ($R-21*
hi!h targets P!EN* is #preg#lated in h#man glio3lastoma ?112@. ($RNA-1## is
#preg#lated in 3reast, l#ng and se(eral hematopoieti! malignan!ies ?11;@. <hile the
e7a!t me!hanism of a!tion of ($R-1## is still #n!lear, there are s#ggestions that it may
play a role in !lass sit!h re!om3ination pro!ess 3y targeting A:D Ha!ti(ation-ind#!ed
!ytidine deaminaseI ?11C@. The on!ogeni! ($R-1+,2 !l#ster, hi!h targets pro-
apoptoti! gene B$(, is fo#nd o(ere7pressed in se(eral kinds of !an!er ?11@.
%hanges in mi'A e7pression !an 3e a!hie(ed thro#gh (ario#s me!hanisms
in!l#ding !hromosomal a3normalities, trans!ription fa!tor 3inding and epigeneti!
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 22/56
22
alterations ?11E@. The initial report 3y Saito et al. H2++EI, hi!h demonstrated that ($R-
12+ , a t#mor s#ppressor mi'A em3edded in a %p$ island, as silen!ed in !an!er 3y
D'A methylation, has led to s#3seB#ent dis!o(ery of se(eral other mi'As hi!h are
also silen!ed 3y epigeneti! me!hanisms in !an!er ?11F, Toyota, 2++ ;+1,11@. Sin!e
s#!h epigeneti! repression of t#mor s#ppressor mi'As !an 3e potentially re(ersed 3y
treatment ith !hromatin modifying dr#gs, they !an ser(e as promising targets for
epigeneti! therapy. Saito et al. s#!!essf#lly demonstrated re-a!ti(ation of ($R-12+ in T2C
3ladder !an!er !ells folloing treatment ith !hromatin modifying dr#gs in!l#ding D'A
methylation and DA% inhi3itors ?EC,111@. S#!h dr#g ind#!ed a!ti(ation of t#mor
s#ppressor mi'As holds great promise for the f#t#re of !an!er therape#ti!s.
The Cancer Ste% Cell M"el
e!ent ork s#ggests that the glo3al epigeneti! !hanges in !an!er, may in(ol(e
the dysreg#lation of h#ndreds of genes d#ring t#morigenesis. The me!hanism 3y hi!h a
t#mor !ell a!!#m#lates s#!h idespread epigeneti! a3normalities d#ring !an!er
de(elopment is still not f#lly #nderstood. The sele!ti(e ad(antage of these epim#tations
d#ring t#mor progression is possi3le, 3#t it is #nlikely that the m#ltit#de of epigeneti!
alterations that reside in a !an!er epigenome o!!#r in a random fashion and then
a!!#m#late inside the t#mor d#e to !lonal sele!tion. A more pla#si3le e7planation o#ld
3e that the a!!#m#lation of s#!h glo3al epigenomi! a3normalities arises from initial
alterations in the !entral epigeneti! !ontrol ma!hinery, hi!h o!!#r at a (ery early stage
of neoplasti! e(ol#tion. S#!h initiating e(ents !an predispose t#mor !ells to gain f#rther
epim#tations d#ring t#mor progression in a fashion similar to a!!#m#lation of the geneti!
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 23/56
2;
alterations that o!!#rs folloing defe!ts in D'A repair ma!hinery in !an!er. The =!an!er
stem !ell> model s#ggests that the epigeneti! !hanges, hi!h o!!#r in normal stem or
progenitor !ells, are the earliest e(ents in !an!er initiation ?E@. The idea that these initial
e(ents o!!#r in stem !ell pop#lations is s#pported 3y the !ommon finding that epigeneti!
a3errations are some of the earliest e(ents that o!!#r in (ario#s types of !an!er and also
3y the dis!o(ery that normal tiss#es ha(e altered progenitor !ells in !an!er patients
?FE,11,12+@. This stem !ell 3ased !an!er initiation model is !onsistent ith the
o3ser(ation that t#mors !ontain a heterogeneo#s pop#lation of !ells ith di(erse
t#morigeni! properties ?121@. Sin!e epigeneti! me!hanisms are !entral to maintenan!e of
stem !ell identity ?;;,122@, it is reasona3le to spe!#late that their disr#ption may gi(e rise
to a high risk a3errant progenitor !ell pop#lation hi!h !an #ndergo transformation on
gain of s#3seB#ent geneti! gatekeeper m#tations. This epigeneti! disr#ption !an lead to
an o(erall in!rease in n#m3er of progenitor !ells along ith an in!rease in their a3ility to
maintain their stem !ell state, forming a high risk s#3strate pop#lation hi!h !an readily
3e!ome neoplasti! on gain of additional geneti! m#tations ?C@.
Se(eral findings ha(e re!ently emerged in s#pport of the =!an!er stem !ell>
model. "i!e ith a loss of imprinting H)L:I at the IGF2 lo!#s and an Ap. m#tation sho
an e7pansion in the progenitor !ell pop#lation of the intestinal epitheli#m, ith the
epithelial !ells shoing higher e7pression of progenitor !ell markers and shifting toards
a less-differentiated state ?12;@. These mi!e ere also at a higher risk for intestinal
t#mors relati(e to !ontrol mi!e ?12;@. :nterestingly, h#mans ith )L: of IGF2 also sho
a similar de-differentiation of normal !oloni! m#!osa !ells along ith a higher risk for
!olore!tal !an!er ?FE@. Also, stem !ell-like !hara!teristi!s of t#mor !ells ere displayed
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 24/56
2C
thro#gh s#!!essf#l !loning of mo#se melanoma and med#llo3lastoma n#!lei to form
3lasto!ysts and !himeri! mi!e ?12C@.
D'A methylation ind#!ed silen!ing of genes in(ol(ed in the reg#lation of stem&
pre!#rsor !ells self reneal !apa!ity, s#!h as p16* APC* SFRPs et!., is !ommonly
o3ser(ed in the early stages of !olon and other !an!ers ?C@. A3errant silen!ing of these so
!alled =epigeneti! gatekeeper> genes in !onditions of !hroni! stress, s#!h as
inflammation, ena3les stem&pre!#rsor !ells to gain infinite reneal !apa!ity there3y
3e!oming immortal. These pre-in(asi(e immortal stem !ells are sele!ted for and then
form a pool of a3normal pre!#rsor !ells that !an #ndergo f#rther geneti! m#tations
leading to t#morigenesis ?C,12@ . #man 0S !ells ith !an!er-!ell !hara!teristi!s
in!l#ding higher freB#en!y of teratoma-initiating !ells HT:%sI, groth fa!tor and ni!he
independen!e ha(e also 3een fo#nd ?12E@. These partially transformed stem !ells display
a higher e7pression of pl#ripoten!y markers s#ggesting their enhan!ed =stemness> along
ith high proliferati(e !apa!ity ?12E@.
Poly!om3 proteins, hi!h !ontrol the silen!ing of de(elopmental reg#lators in 0S
!ells, pro(ide another link 3eteen stem !ell 3iology and !an!er initiation. Poly!om3
proteins are !ommonly #preg#lated in (ario#s forms of !an!er ?2@. :n addition, genes
that are marked 3y poly!om3 repressi(e mark ;K2Fme; in 0S !ells are often
methylated in !an!er s#ggesting the presen!e of a shared reg#latory frameork, hi!h
!onne!ts !an!er !ells ith stem&progenitor !ell pop#lations. S#!h findings s#pport the
hypothesis of epigeneti!s playing a !entral role in early neoplasia and !an!er stem !ells
3eing the key perpet#ators of !an!er ?;,C@.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 25/56
2
Epigenetic Therapy # Cancer
The re(ersi3le nat#re of the profo#nd epigeneti! !hanges that o!!#r in !an!er has
led to the possi3ility of =epigeneti! therapy> as a treatment option. The aim of epigeneti!
therapy is to re(erse the !a#sal epigeneti! a3errations that o!!#r in !an!er, leading to the
restoration of a =normal epigenome>. "any epigeneti! dr#gs ha(e 3een dis!o(ered in the
re!ent past that !an effe!ti(ely re(erse D'A methylation and histone modifi!ation
a3errations that o!!#r in !an!er ?@. D'A methylation inhi3itors ere among the first
epigeneti! dr#gs proposed for #se as !an!er therape#ti!s. The remarka3le dis!o(ery that
treatment ith !ytoto7i! agents, -a8a!ytidine H-a8a-%I and -a8a-2-deo7y!ytidine H-
a8a-%dI lead to the inhi3ition of D'A methylation hi!h ind#!ed gene e7pression and
!a#sed differentiation in !#lt#red !ells led to the reali8ation of the potential #se of these
dr#gs in !an!er therapy ?12F@. These n#!leoside analogs get in!orporated into the D'A
of rapidly groing t#mor !ells d#ring repli!ation and inhi3it D'A methylation 3y
trapping D'A methyltransferases onto the D'A, leading to their depletion inside the !ell
?2@. This dr#g ind#!ed red#!tion of D'A methylation !a#ses groth inhi3ition in !an!er
!ells 3y a!ti(ating t#mor s#ppressor genes a3errantly silen!ed in !an!er ?@. -a8a-%
Ha8a!itidineI and -a8a-%d Hde!ita3ineI ha(e no 3een 9DA appro(ed for #se in the
treatment of myelodysplasti! syndromes H"DSI and promising res#lts ha(e also emerged
from the treatment of other hematologi!al malignan!ies s#!h as a!#te myeloid le#kemia
HA")I and !hroni! myeloid le#kemia H%")I #sing these dr#gs ?12@. The possi3le
!lini!al #se of other impro(ed D'A methylation inhi3itors s#!h as 8e3#larine, hi!h !an
3e orally administered, is !#rrently #nder in(estigation ?12@.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 26/56
2E
The a3ility of these dr#gs to 3e in!orporated into D'A raises !on!erns regarding
their potential to7i! effe!t on normal !ells. oe(er, sin!e these dr#gs only a!t on
di(iding !ells, one !an arg#e that treatment ith these dr#gs sho#ld mainly target rapidly
di(iding t#mor !ells and sho#ld ha(e minimal effe!ts on sloly di(iding normal !ells.
This arg#ment has 3een s#pported 3y st#dies demonstrating minimal side effe!ts of long-
term treatment ith D'A methylation inhi3itors ?1;+@. 'e(ertheless, an alternati(e
approa!h in(ol(ing the de(elopment of non-n#!leoside !ompo#nds, hi!h !an
effe!ti(ely inhi3it D'A methylation itho#t 3eing in!orporated into D'A, is also 3eing
a!ti(ely p#rs#ed. De(elopment of se(eral small mole!#le inhi3itors s#!h as S$:-1+2F,
$1+ and "$ is a step in that dire!tion ?1;1,1;2@. These mole!#les !an a!hie(e their
inhi3itory effe!ts 3y either 3lo!king !atalyti!&!ofa!tor 3inding sites of D'"Ts or 3y
targeting their reg#latory m'A seB#en!esM hoe(er, the eak inhi3itory potential of
these dr#gs indi!ates a need for the de(elopment of more potent inhi3itory !ompo#nds in
f#t#re.
A3errant gene silen!ing in !an!er is also asso!iated ith a !on!omitant loss of
histone a!etylation. e-esta3lishing normal histone a!etylation patterns thro#gh treatment
ith DA% inhi3itors has 3een shon to ha(e anti-t#morigeni! effe!ts in!l#ding groth
arrest, apoptosis and the ind#!tion of differentiation. These anti-proliferati(e effe!ts of
DA% inhi3itors are mediated 3y their a3ility to rea!ti(ate silen!ed t#mor s#ppressor
genes ?1;;@. SAA Hs#3eroylanilide hydro7ami! a!idI, hi!h is an DA% inhi3itor, has
no 3een appro(ed for #se in !lini! for treatment of T !ell !#taneo#s lymphoma. Se(eral
other DA% inhi3itors s#!h as depsipeptide and phenyl3#tyrate are !#rrently #nder
!lini!al trials ?1;1@.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 27/56
2F
The intera!tion 3eteen different !omponents of the epigeneti! ma!hinery has led
to the e7ploration of effe!ti(e !om3inatorial !an!er treatment strategies, hi!h in(ol(e
#se of 3oth D'A methylation and DA% inhi3itors together. S#!h !om3ination
treatment strategies ha(e 3een fo#nd to 3e more effe!ti(e than indi(id#al treatment
approa!hes. 9or e7ample, the de-repression of !ertain p#tati(e t#mor s#ppressor genes
as only seen hen -A8a-%d and tri!hostatin A ere !om3ined ?1;C@. Anti-
t#morigeni! effe!ts of depsipeptide ere enhan!ed hen le#kemi! !ells ere
sim#ltaneo#sly treated ith -A8a-%d ?1;@. Synergisti! a!ti(ities of D'A methylation
and DA% inhi3itors ere also demonstrated in a st#dy shoing greater red#!tion of
l#ng t#mor formation in mi!e hen treated ith phenyl3#tyrate and -A8a-%d together
?1;E@.
Apart from D'A methylation and DA% inhi3itors, histone methyltransferase
inhi3itors ha(e also 3een a!ti(ely e7plored re!ently. Lne s#!h inhi3itor !ompo#nd,
DO'ep, as shon to s#!!essf#lly ind#!e apoptosis in !an!er !ells 3y sele!ti(ely
targeting poly!om3 repressi(e !omple7 2 HP%2I proteins, hi!h are generally
o(ere7pressed in !an!er ?1;F@. <hile the spe!ifi!ity of DO'ep as !hallenged in a
s#3seB#ent st#dy ?1;@, these findings reinfor!e the potential of "T inhi3itors and the
need for f#rther de(elopment of spe!ifi! histone methylation inhi3itors.
mi'As also represent promising targets for epigeneti! therapy. The finding 3y
Saito et al. H2++EI that donreg#lation of the on!ogene %)E (ia re-a!ti(ation of ($R-
12+ folloing treatment ith -A8a-%d and C-phenyl3#tyri! a!id strongly ad(o!ates in
fa(or of the potential of a mi'A 3ased treatment strategy ?111@. :n addition, the
introd#!tion of syntheti! mi'As, hi!h mimi! t#mor s#ppressor mi'As, !an 3e #sed
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 28/56
2
to sele!ti(ely repress on!ogenes in t#mors. mi'As, s#!h as ($R-101 hi!h targets
0O2 ?EE@, !an 3e #sed to reg#late the a3errant epigeneti! ma!hinery in !an!er hi!h
may assist in restoring of the normal epigenome. oe(er, the la!k of effi!ient deli(ery
methods is a ma4or h#rdle in the effe!ti(e #se of this strategy. De(elopment of effi!ient
(ehi!le mole!#les for targeted deli(ery of syntheti! mi'As to t#mor !ells is of prime
importan!e in f#t#re.
($t$re Prspects an" Challenges
The epigeneti! re(ol#tion that has !ome a3o#t in the field of 3iology d#ring the
last fe de!ades has !hallenged the long-held traditional (ie of the geneti! !ode 3eing
the key determinant of !ell#lar gene f#n!tion and its alteration 3eing the ma4or !a#se of
h#man diseases. Ad(an!es made in the field of !an!er epigeneti!s ha(e led to the
reali8ation that the pa!kaging of the genome is potentially as important as the genome
itself, in reg#lating the essential !ell#lar pro!esses reB#ired for preser(ing !ell#lar
identity and also in gi(ing rise to disease states like !an!er. Deeper #nderstandings of the
glo3al patterns of these epigeneti! modifi!ations and their !orresponding !hanges in
!an!er ha(e ena3led the design of 3etter treatment strategies. A !om3inatorial approa!h
#tili8ing different epigeneti! therape#ti! approa!hes along ith standard !hemotherapy
holds signifi!ant promise for s#!!essf#l treatment of !an!er in f#t#re. S#!h approa!hes
might also help in sensiti8ing !an!er !ells, espe!ially !an!er stem !ells, hi!h are
refra!tory to standard !hemotherapy. 9#rther #nderstanding of !an!er stem !ells, along
ith de(elopment of more spe!ifi! epigeneti! dr#gs may hold the key to o#r a3ility to
s#!!essf#lly reset the a3normal !an!er epigenome.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 29/56
2
RE(ERENCES
1. <addington, %.. H1C2I The epigenotype. Endeavo/& +, 1-2+.
2. 0gger, $., )iang, $., Apari!io, A. and Jones, P.A. H2++CI 0pigeneti!s in h#man
disease and prospe!ts for epigeneti! therapy. Na%/&e, ,-., CF-E;.
;. Jones, P.A. and aylin, S.. H2++2I The f#ndamental role of epigeneti! e(ents in
!an!er. Na% Rev Gene% , /, C1-2.
C. Jones, P.A. and aylin, S.. H2++FI The epigenomi!s of !an!er. Ce)) , +-0, E;-
2.
. Jones, P.A. and )aird, P.<. H1I %an!er epigeneti!s !omes of age. Na% Gene% ,
-+, 1E;-F.
E. 9ein3erg, A.P., Lhlsson, . and enikoff, S. H2++EI The epigeneti! progenitor
origin of h#man !an!er. Na% Rev Gene% , 1, 21-;;.
F. Jones, P.A. and "artienssen, . H2++I A 3l#eprint for a #man 0pigenome
Pro4e!t/ the AA% #man 0pigenome <orkshop. Can.e& Res, 23, 112C1-E.
. Qoo, %.. and Jones, P.A. H2++EI 0pigeneti! therapy of !an!er/ past, present and
f#t#re. Na% Rev &/ $s.ov, 3, ;F-+.
. )#ger, K., "ader, A.<., i!hmond, .K., Sargent, D.9. and i!hmond, T.J.
H1FI %rystal str#!t#re of the n#!leosome !ore parti!le at 2. A resol#tion.
Na%/&e, /0., 21-E+.
1+. ernstein, .0., "eissner, A. and )ander, 0.S. H2++FI The mammalian
epigenome. Ce)) , +-0, EE-1.
11. S#8#ki, ".". and ird, A. H2++I D'A methylation lands!apes/ pro(o!ati(e
insights from epigenomi!s. Na% Rev Gene% , ., CE-FE.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 30/56
;+
12. Ko#8arides, T. H2++FI %hromatin modifi!ations and their f#n!tion. Ce)) , +-0, E;-
F+.
1;. Ohang, ., Pan, ., %o33, $.P. and Anderson, T.A. H2++FI mi!ro'As as
on!ogenes and t#mor s#ppressors. ev B$o) , /4-, 1-12.
1C. Jiang, %. and P#gh, .9. H2++I '#!leosome positioning and gene reg#lation/
ad(an!es thro#gh genomi!s. Na% Rev Gene% , +4, 1E1-F2.
1. ird, A. H2++2I D'A methylation patterns and epigeneti! memory. Genes ev,
+2, E-21.
1E. Takai, D. and Jones, P.A. H2++2I %omprehensi(e analysis of %p$ islands in
h#man !hromosomes 21 and 22. P&o. Na%) A.ad S.$ U S A, .., ;FC+-.
1F. <ang, Q. and )e#ng, 9.%. H2++CI An e(al#ation of ne !riteria for %p$ islands
in the h#man genome as gene markers. B$o$n'o&(a%$.s, -4, 11F+-F.
1. 0!khardt, 9., )ein, J., %ortese, ., akyan, N.K., Attood, J., #rger, ".,
#rton, J., %o7, T.N., Da(ies, ., Don, T.A., aefliger, %., orton, ., oe,
K., Ja!kson, D.K., K#nde, J., Koenig, %., )iddle, J., 'i3lett, D., Ltto, T., Pettett,
., Seemann, S., Thompson, %., <est, T., ogers, J., Llek, A., erlin, K. and
e!k, S. H2++EI D'A methylation profiling of h#man !hromosomes E, 2+ and 22.
Na% Gene% , /0, 1;F-.
1. :llingorth, ., Kerr, A., Deso#sa, D., Jorgensen, ., 0llis, P., Stalker, J.,
Ja!kson, D., %lee, %., Pl#m3, ., ogers, J., #mphray, S., %o7, T., )angford, %.
and ird, A. H2++I A no(el %p$ island set identifies tiss#e-spe!ifi! methylation
at de(elopmental gene lo!i. PLoS B$o) , 2, e22.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 31/56
;1
2+. Prendergast, $.%. and Oiff, 0.. H11I "ethylation-sensiti(e seB#en!e-spe!ifi!
D'A 3inding 3y the !-"y! 3asi! region. S.$en.e, -3+, 1E-.
21. <att, 9. and "olloy, P.). H1I %ytosine methylation pre(ents 3inding to D'A
of a e)a !ell trans!ription fa!tor reB#ired for optimal e7pression of the
adeno(ir#s ma4or late promoter. Genes ev, -, 11;E-C;.
22. Jones, P.)., Neenstra, $.J., <ade, P.A., Nermaak, D., Kass, S.U., )ands3erger,
'., Stro#3o#lis, J. and <olffe, A.P. H1I "ethylated D'A and "e%P2 re!r#it
histone dea!etylase to repress trans!ription. Na% Gene% , +., 1F-1.
2;. 'an, ., 'g, .., Johnson, %.A., )aherty, %.D., T#rner, ."., 0isenman, .'.
and ird, A. H1I Trans!riptional repression 3y the methyl-%p$-3inding
protein "e%P2 in(ol(es a histone dea!etylase !omple7. Na%/&e, /./, ;E-.
2C. Kim, $.D., 'i, J., Kelesogl#, '., o3erts, .J. and Pradhan, S. H2++2I %o-
operation and !omm#ni!ation 3eteen the h#man maintenan!e and de no(o D'A
H!ytosine-I methyltransferases. E(bo , -+, C1;-.
2. Lkano, "., ell, D.<., a3er, D.A. and )i, 0. H1I D'A methyltransferases
Dnmt;a and Dnmt;3 are essential for de no(o methylation and mammalian
de(elopment. Ce)) , .., 2CF-F.
2E. 9#ts!her, .<., Lshiro, "."., <o8niak, .J., oltan, '., anigan, %.)., D#an,
. and Domann, 9.0. H2++2I ole for D'A methylation in the !ontrol of !ell type
spe!ifi! maspin e7pression. Na% Gene% , /+, 1F-.
2F. attori, '., 'ishino, K., Ko, Q.$., attori, '., Lhgane, J., Tanaka, S. and Shiota,
K. H2++CI 0pigeneti! !ontrol of mo#se L!t-C gene e7pression in em3ryoni! stem
!ells and tropho3last stem !ells. B$o) C3e(, -1., 1F+E;-.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 32/56
;2
2. Jen#ein, T. and Allis, %.D. H2++1I Translating the histone !ode. S.$en.e, -./,
1+FC-+.
2. e33es, T.., Thorne, A.<. and %rane-o3inson, %. H1I A dire!t link
3eteen !ore histone a!etylation and trans!riptionally a!ti(e !hromatin. E(bo ,
1, 1;-C+2.
;+. )iang, $., )in, J.%., <ei, N., Qoo, %., %heng, J.%., 'g#yen, %.T., <eisen3erger,
D.J., 0gger, $., Takai, D., $on8ales, 9.A. and Jones, P.A. H2++CI Distin!t
lo!ali8ation of histone ; a!etylation and ;-KC methylation to the trans!ription
start sites in the h#man genome. P&o. Na%) A.ad S.$ U S A, +4+, F;F-E2.
;1. arski, A., %#ddapah, S., %#i, K., oh, T.Q., S!hones, D.0., <ang, O., <ei, $.,
%hepele(, :. and Ohao, K. H2++FI igh-resol#tion profiling of histone
methylations in the h#man genome. Ce)) , +-., 2;-;F.
;2. <ang, O., Oang, %., osenfeld, J.A., S!hones, D.0., arski, A., %#ddapah, S.,
%#i, K., oh, T.Q., Peng, <., Ohang, ".R. and Ohao, K. H2++I %om3inatorial
patterns of histone a!etylations and methylations in the h#man genome. Na%
Gene% , ,4, F-+;.
;;. "ikkelsen, T.S., K#, "., Jaffe, D.., :ssa!, ., )ie3erman, 0., $ianno#kos, $.,
Al(are8, P., ro!kman, <., Kim, T.K., Ko!he, .P., )ee, <., "endenhall, 0.,
LDono(an, A., Presser, A., #ss, %., ie, ., "eissner, A., <ernig, ".,
Jaenis!h, ., '#s3a#m, %., )ander, 0.S. and ernstein, .0. H2++FI $enome-ide
maps of !hromatin state in pl#ripotent and lineage-!ommitted !ells. Na%/&e, ,,0,
;-E+.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 33/56
;;
;C. ingrose, ). and Paro, . H2++FI Poly!om3&Trithora7 response elements and
epigeneti! memory of !ell identity. eve)op(en% , +/,, 22;-;2.
;. ernstein, .0., "ikkelsen, T.S., ie, ., Kamal, "., #e3ert, D.J., %#ff, J., 9ry,
., "eissner, A., <ernig, "., Plath, K., Jaenis!h, ., <ags!hal, A., 9eil, .,
S!hrei3er, S.). and )ander, 0.S. H2++EI A 3i(alent !hromatin str#!t#re marks key
de(elopmental genes in em3ryoni! stem !ells. Ce)) , +-3, ;1-2E.
;E. A8#ara, N., Perry, P., Sa#er, S., Spi(ako(, "., Jorgensen, .9., John, .".,
$o#ti, "., %asano(a, "., <arnes, $., "erkens!hlager, ". and 9isher, A.$.
H2++EI %hromatin signat#res of pl#ripotent !ell lines. Na% Ce)) B$o) , 0, ;2-.
;F. <en, ., <#, ., Shinkai, Q., :ri8arry, .A. and 9ein3erg, A.P. H2++I )arge
histone ; lysine dimethylated !hromatin 3lo!ks disting#ish differentiated from
em3ryoni! stem !ells. Na% Gene% , ,+, 2CE-+.
;. a3erland, "., "ontgomery, .). and Llson, 0.'. H2++I The many roles of
histone dea!etylases in de(elopment and physiology/ impli!ations for disease and
therapy. Na% Rev Gene% , +4, ;2-C2.
;. Shi, Q. H2++FI istone lysine demethylases/ emerging roles in de(elopment,
physiology and disease. Na% Rev Gene% , 0, 2-;;.
C+. %edar, . and ergman, Q. H2++I )inking D'A methylation and histone
modifi!ation/ patterns and paradigms. Na% Rev Gene% , +4, 2-;+C.
C1. Ta!hi3ana, "., "ats#m#ra, Q., 9#k#da, "., Kim#ra, . and Shinkai, Q. H2++I
$a&$)P !omple7es independently mediate ;K and D'A methylation to
silen!e trans!ription. E(bo , -1, 2E1-+.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 34/56
;C
C2. )ehnert8, ., Ueda, Q., Deri4!k, A.A., ra#ns!heig, U., Pere8-#rgos, ).,
K#3i!ek, S., %hen, T., )i, 0., Jen#ein, T. and Peters, A.. H2++;I S#(;h-
mediated histone ; lysine methylation dire!ts D'A methylation to ma4or
satellite repeats at peri!entri! hetero!hromatin. C/&& B$o) , +/, 112-2++.
C;. Ohao, R., ank, $., Tan, Q.T., )i, ., "orit8, .)., Simpson, .J., %err#ti, ).,
%#rtis, D.J., Patel, D.J., Allis, %.D., %#nningham, J.". and Jane, S.". H2++I
P"T-mediated methylation of histone C; re!r#its D'"T;A, !o#pling
histone and D'A methylation in gene silen!ing. Na% S%&/.% Mo) B$o) , +2, ;+C-11.
CC. 0ste(e, P.L., %hin, .$., enner, J., 9eehery, $.., Samaranayake, "., orit8,
$.A., Ja!o3sen, S.0. and Pradhan, S. H2++I eg#lation of D'"T1 sta3ility
thro#gh S0TF-mediated lysine methylation in mammalian !ells. P&o. Na%) A.ad
S.$ U S A, +42, +FE-1.
C. <ang, J., e(i, S., K#rash, J.K., )ei, ., $ay, 9., a4ko, J., S#, ., S#n, <.,
%hang, ., #, $., $a#det, 9., )i, 0. and %hen, T. H2++I The lysine demethylase
)SD1 HKD"1I is reB#ired for maintenan!e of glo3al D'A methylation. Na%
Gene% , ,+, 12-.
CE. 9#ks, 9., #rd, P.J., <olf, D., 'an, ., ird, A.P. and Ko#8arides, T. H2++;I The
methyl-%p$-3inding protein "e%P2 links D'A methylation to histone
methylation. B$o) C3e(, -10, C+;-C+.
CF. "a(ri!h, T.'., :oshikhes, :.P., Nenters, .J., Jiang, %., Tomsho, ).P., Ri, J.,
S!h#ster, S.%., Al3ert, :. and P#gh, .9. H2++I A 3arrier n#!leosome model for
statisti!al positioning of n#!leosomes thro#gho#t the yeast genome. Geno(e Res,
+0, 1+F;-;.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 35/56
;
C. Q#an, $.%., )i#, Q.J., Dion, ".9., Sla!k, ".D., <#, ).9., Alts!h#ler, S.J. and
ando, L.J. H2++I $enome-s!ale identifi!ation of n#!leosome positions in S.
!ere(isiae. S.$en.e, /4., E2E-;+.
C. Shi(asamy, S., hinge, A., Ohao, Q., Jones, S., irst, ". and :yer, N.. H2++I
Dynami! remodeling of indi(id#al n#!leosomes a!ross a e#karyoti! genome in
response to trans!riptional pert#r3ation. PLoS B$o) , 2, eE.
+. )in, J.%., Jeong, S., )iang, $., Takai, D., 9atemi, "., Tsai, Q.%., 0gger, $., $al-
Qam, 0.'. and Jones, P.A. H2++FI ole of n#!leosomal o!!#pan!y in the
epigeneti! silen!ing of the ")1 %p$ island. Can.e& Ce)) , +-, C;2-CC.
1. $al-Qam, 0.'., Jeong, S.,Tanay A., 0gger, 0., )ee, A.s., and Jones, P.A. H2++EI
%onstit#ti(e '#!leosome Depletion and Lrdered 9a!tor Assem3ly at the GRP F
Promoter e(ealed 3y Single "ole!#le 9ootprinting. P)os Gene%$.s, -, e1E+.
2. S!hones, D.0., %#i, K., %#ddapah, S., oh, T.Q., arski, A., <ang, O., <ei, $.
and Ohao, K. H2++I Dynami! reg#lation of n#!leosome positioning in the h#man
genome. Ce)) , +/-, F-.
;. Smith, %.). and Peterson, %.). H2++I ATP-dependent !hromatin remodeling.
C/&& !op ev B$o) , 23, 11-C.
C. arikrishnan, K.'., %ho, ".O., aker, 0.K., Pal, S., assal, S., rasa!!hio, D.,
<ang, )., %raig, J."., Jones, P.)., Sif, S. and 0l-Lsta, A. H2++I rahma links
the S<:&S'9 !hromatin-remodeling !omple7 ith "e%P2-dependent
trans!riptional silen!ing. Na% Gene% , /1, 2C-EC.
. <yso!ka, J., Sig#t, T., iao, ., "ilne, T.A., Kon, S.Q., )andry, J., Ka#er,
"., Ta!kett, A.J., %hait, .T., adenhorst, P., <#, %. and Allis, %.D. H2++EI A
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 36/56
;E
PD finger of 'U9 !o#ples histone ; lysine C trimethylation ith !hromatin
remodelling. Na%/&e, ,,-, E-+.
E. Santenard, A. and Torres-Padilla, ".0. H2++I 0pigeneti! reprogramming in
mammalian reprod#!tion/ !ontri3#tion from histone (ariants. Ep$ene%$.s, ,, +-C.
F. Sarma, K. and ein3erg, D. H2++I istone (ariants meet their mat!h. Na% Rev
Mo) Ce)) B$o) , 2, 1;-C.
. Jin, %. and 9elsenfeld, $. H2++FI '#!leosome sta3ility mediated 3y histone
(ariants ;.; and 2A.O. Genes ev, -+, 11-2.
. Oil3erman, D., %oleman-Derr, D., allinger, T. and enikoff, S. H2++I istone
2A.O and D'A methylation are m#t#ally antagonisti! !hromatin marks. Na%/&e,
,32, 12-.
E+. %reyghton, ".P., "arko#laki, S., )e(ine, S.S., anna, J., )odato, ".A., Sha, K.,
Qo#ng, .A., Jaenis!h, . and oyer, ).A. H2++I 2AO is enri!hed at poly!om3
!omple7 target genes in 0S !ells and is ne!essary for lineage !ommitment. Ce)) ,
+/3, EC-E1.
E1. Olatano(a, J. and Thakar, A. H2++I 2A.O/ (ie from the top. S%&/.%/&e, +2,
1EE-F.
E2. S(otelis, A., $e(ry, '. and $a#drea#, ). H2++I eg#lation of gene e7pression
and !ell#lar proliferation 3y histone 2A.O. B$o.3e( Ce)) B$o) , 01, 1F-.
E;. e, ). and annon, $.J. H2++CI "i!ro'As/ small 'As ith a 3ig role in gene
reg#lation. Na% Rev Gene% , 3, 22-;1.
EC. Saito, Q. and Jones, P.A. H2++EI 0pigeneti! a!ti(ation of t#mor s#ppressor
mi!ro'As in h#man !an!er !ells. Ce)) C4.)e, 3, 222+-2.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 37/56
;F
E. 9a33ri, "., $ar8on, ., %immino, A., )i#, O., Oanesi, '., %allegari, 0., )i#, S.,
Alder, ., %ostinean, S., 9ernande8-%ymering, %., Nolinia, S., $#ler, $.,
"orrison, %.D., %han, K.K., "ar!#!!i, $., %alin, $.A., #e3ner, K. and %ro!e,
%.". H2++FI "i!ro'A-2 family re(erts a3errant methylation in l#ng !an!er 3y
targeting D'A methyltransferases ;A and ;. P&o. Na%) A.ad S.$ U S A, +4,,
1+-1+.
EE. 9riedman, J."., )iang, $., )i#, %.%., <olff, 0."., Tsai, Q.%., Qe, <., Oho#, .
and Jones, P.A. H2++I The p#tati(e t#mor s#ppressor mi!ro'A-1+1 mod#lates
the !an!er epigenome 3y repressing the poly!om3 gro#p protein 0O2. Can.e&
Res, 2., 2E2;-.
EF. 9ein3erg, A.P. and Nogelstein, . H1;I ypomethylation disting#ishes genes of
some h#man !an!ers from their normal !o#nterparts. Na%/&e, /4+, -2.
E. iggs, A.D. and Jones, P.A. H1;I -methyl!ytosine, gene reg#lation, and
!an!er. Adv Can.e& Res, ,4, 1-;+.
E. odrig#e8, J., 9rigola, J., Nendrell, 0., isB#es, .A., 9raga, ".9., "orales, %.,
"oreno, N., 0steller, "., %apella, $., i3as, ". and Peinado, ".A. H2++EI
%hromosomal insta3ility !orrelates ith genome-ide D'A demethylation in
h#man primary !olore!tal !an!ers. Can.e& Res, 22, CE2-CE.
F+. 0den, A., $a#det, 9., <aghmare, A. and Jaenis!h, . H2++;I %hromosomal
insta3ility and t#mors promoted 3y D'A hypomethylation. S.$en.e, /44, C.
F1. oard, $., 0iges, ., $a#det, 9., Jaenis!h, . and 0den, A. H2++I A!ti(ation
and transposition of endogeno#s retro(iral elements in hypomethylation ind#!ed
t#mors in mi!e. 5n.oene, -1, C+C-.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 38/56
;
F2. 0hrli!h, ". H2++;I The :%9 syndrome, a D'A methyltransferase ; defi!ien!y
and imm#nodefi!ien!y disease. C)$n I((/no) , +4., 1F-2.
F;. <ilson, A.S., Poer, .0. and "olloy, P.). H2++FI D'A hypomethylation and
h#man diseases. B$o.3$( B$op34s A.%a, +113, 1;-E2.
FC. ainier, S., Johnson, ).A., Do3ry, %.J., Ping, A.J., $r#ndy, P.0. and 9ein3erg,
A.P. H1;I ela7ation of imprinted genes in h#man !an!er. Na%/&e, /2-, FCF-.
F. Lgaa, L., 0!!les, ".., S8eto, J., "!'oe, ).A., Q#n, K., "a, ".A., Smith,
P.J. and ee(e, A.0. H1;I ela7ation of ins#lin-like groth fa!tor :: gene
imprinting impli!ated in <ilms t#mo#r. Na%/&e, /2-, FC-1.
FE. %#i, ., %r#8-%orrea, "., $iardiello, 9."., #t!heon, D.9., Kafonek, D..,
randen3#rg, S., <#, Q., e, ., Poe, '.. and 9ein3erg, A.P. H2++;I )oss of
:$92 imprinting/ a potential marker of !olore!tal !an!er risk. S.$en.e, -.., 1F;-
.
FF. $reger, N., Passarge, 0., opping, <., "essmer, 0. and orsthemke, . H1I
0pigeneti! !hanges may !ontri3#te to the formation and spontaneo#s regression
of retino3lastoma. H/( Gene% , 0/, 1-.
F. aylin, S.. H2++I D'A methylation and gene silen!ing in !an!er. Na% C)$n
P&a.% 5n.o) , - S$ppl +, SC-11.
F. )ong, %., Qin, ., )#, R., Oho#, ., #, J., Qang, Q., Q#, 9. and Q#an, Q. H2++FI
Promoter hypermethylation of the U'; gene in esophageal sB#amo#s !ell
!ar!inoma. Can.e& Inves% , -3, E-+.
+. Akiyama, Q., <atkins, '., S#8#ki, ., Jair, K.<., (an 0ngeland, "., 0steller, ".,
Sakai, ., en, %.Q., Q#asa, Q., erman, J.$. and aylin, S.. H2++;I $ATA-C
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 39/56
;
and $ATA- trans!ription fa!tor genes and potential donstream antit#mor target
genes are epigeneti!ally silen!ed in !olore!tal and gastri! !an!er. Mo) Ce)) B$o) ,
-/, C2-;.
1. Di %ro!e, )., aker, N.A., %orsaro, "., 9a8i, 9., 9anelli, "., 9aretta, "., 9#ks, 9.,
)o %o!o, 9., Ko#8arides, T., 'er(i, %., "in#!!i, S. and Peli!!i, P.$. H2++2I
"ethyltransferase re!r#itment and D'A hypermethylation of target promoters 3y
an on!ogeni! trans!ription fa!tor. S.$en.e, -.3, 1+F-2.
2. 9rigola, J., Song, J., Stir8aker, %., inshelood, .A., Peinado, ".A. and %lark,
S.J. H2++EI 0pigeneti! remodeling in !olore!tal !an!er res#lts in !oordinate gene
s#ppression a!ross an entire !hromosome 3and. Na% Gene% , /0, C+-.
;. S!hlesinger, Q., Stra#ssman, ., Keshet, :., 9arkash, S., e!ht, "., Oimmerman,
J., 0den, 0., Qakhini, O., en-Sh#shan, 0., e#3inoff, .0., ergman, Q., Simon,
:. and %edar, . H2++FI Poly!om3-mediated methylation on )ys2F of histone ;
pre-marks genes for de no(o methylation in !an!er. Na% Gene% , /., 2;2-E.
C. <ids!hendter, "., 9iegl, ., 0gle, D., "#eller-ol8ner, 0., Spi88o, $., "arth,
%., <eisen3erger, D.J., %ampan, "., Qo#ng, J., Ja!o3s, :. and )aird, P.<. H2++FI
0pigeneti! stem !ell signat#re in !an!er. Na% Gene% , /., 1F-.
. Lhm, J.0., "!$ar(ey, K."., Q#, ., %heng, )., S!h#e3el, K.0., %ope, ).,
"ohammad, .P., %hen, <., Daniel, N.%., Q#, <., erman, D."., Jen#ein, T.,
Pr#itt, K., Sharkis, S.J., <atkins, D.'., erman, J.$. and aylin, S.. H2++FI A
stem !ell-like !hromatin pattern may predispose t#mor s#ppressor genes to D'A
hypermethylation and herita3le silen!ing. Na% Gene% , /., 2;F-C2.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 40/56
C+
E. <eisen3erger, D.J., Siegm#nd, K.D., %ampan, "., Qo#ng, J., )ong, T.:., 9aasse,
".A., Kang, $.., <ids!hendter, "., <eener, D., #!hanan, D., Koh, .,
Simms, )., arker, "., )eggett, ., )e(ine, J., Kim, "., 9ren!h, A.J., Thi3odea#,
S.'., Jass, J., aile, . and )aird, P.<. H2++EI %p$ island methylator phenotype
#nderlies sporadi! mi!rosatellite insta3ility and is tightly asso!iated ith A9
m#tation in !olore!tal !an!er. Na% Gene% , /0, FF-;.
F. 9raga, ".9., allestar, 0., Nillar-$area, A., oi7-%hornet, "., 0spada, J.,
S!hotta, $., onaldi, T., aydon, %., opero, S., Petrie, K., :yer, '.$., Pere8-
osado, A., %al(o, 0., )ope8, J.A., %ano, A., %alasan8, ".J., %olomer, D., Piris,
".A., Ahn, '., :mhof, A., %aldas, %., Jen#ein, T. and 0steller, ". H2++I )oss
of a!etylation at )ys1E and trimethylation at )ys2+ of histone C is a !ommon
hallmark of h#man !an!er. Na% Gene% , /1, ;1-C++.
. alkido#, K., $a#ghan, )., %ook, S., )e#ng, .Q., 'eal, D.0. and o3son, %.'.
H2++CI Upreg#lation and n#!lear re!r#itment of DA%1 in hormone refra!tory
prostate !an!er. P&os%a%e, 3., 1FF-.
. Song, J., 'oh, J.., )ee, J.., 0#n, J.<., Ahn, Q."., Kim, S.Q., )ee, S.., Park,
<.S., Qoo, '.J., )ee, J.Q. and 'am, S.<. H2++I :n!reased e7pression of histone
dea!etylase 2 is fo#nd in h#man gastri! !an!er. Ap($s, ++/, 2EC-.
+. Qang, .J. H2++CI The di(erse s#perfamily of lysine a!etyltransferases and their
roles in le#kemia and other diseases. N/.)e$. A.$ds Res, /-, -FE.
1. 'g#yen, %.T., <eisen3erger, D.J., Neli!es!#, "., $on8ales, 9.A., )in, J.%.,
)iang, $. and Jones, P.A. H2++2I istone ;-lysine methylation is asso!iated
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 41/56
C1
ith a3errant gene silen!ing in !an!er !ells and is rapidly re(ersed 3y -a8a-2-
deo7y!ytidine. Can.e& Res, 2-, ECE-E1.
2. Nalk-)ing3eek, ".0., r#ggeman, S.<. and (an )oh#i8en, ". H2++CI Stem !ells
and !an!erM the poly!om3 !onne!tion. Ce)) , ++0, C+-1.
;. Kondo, Q., Shen, )., Ahmed, S., o#m3er, Q., Sekido, Q., addad, .. and :ssa,
J.P. H2++I Donreg#lation of histone ; lysine methyltransferase $a ind#!es
!entrosome disr#ption and !hromosome insta3ility in !an!er !ells. PLoS 5ne, /,
e2+;F.
C. Kondo, Q., Shen, )., S#8#ki, S., K#rokaa, T., "as#ko, K., Tanaka, Q., Kato, .,
"i8#no, Q., Qokoe, "., S#ga#!hi, 9., irashima, '., Lrito, 0., Lsada, ., Ueda,
., $#o, Q., %hen, ., :ssa, J.P. and Sekido, Q. H2++FI Alterations of D'A
methylation and histone modifi!ations !ontri3#te to gene silen!ing in
hepato!ell#lar !ar!inomas. Hepa%o) Res, /1, FC-;.
. Kri(tso(, A.N. and Armstrong, S.A. H2++FI ")) translo!ations, histone
modifi!ations and le#kaemia stem-!ell de(elopment. Na% Rev Can.e& , 1, 2;-;;.
E. %loos, P.A., %hristensen, J., Agger, K. and elin, K. H2++I 0rasing the methyl
mark/ histone demethylases at the !enter of !ell#lar differentiation and disease.
Genes ev, --, 111-C+.
F. Shi, Q., )an, 9., "atson, %., "#lligan, P., <hetstine, J.., %ole, P.A., %asero,
.A. and Shi, Q. H2++CI istone demethylation mediated 3y the n#!lear amine
o7idase homolog )SD1. Ce)) , ++., C1-;.
. "et8ger, 0., <issmann, "., Qin, '., "#ller, J."., S!hneider, ., Peters, A..,
$#nther, T., #ettner, . and S!h#le, . H2++I )SD1 demethylates repressi(e
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 42/56
C2
histone marks to promote androgen-re!eptor-dependent trans!ription. Na%/&e,
,/1, C;E-.
. S!h#lte, J.., )im, S., S!hramm, A., 9riedri!hs, '., Koster, J., Nersteeg, ., Lra,
:., Pa4tler, K., Klein-itpass, )., K#hfittig-K#lle, S., "et8ger, 0., S!h#le, .,
0ggert, A., #ettner, . and Kirfel, J. H2++I )ysine-spe!ifi! demethylase 1 is
strongly e7pressed in poorly differentiated ne#ro3lastoma/ impli!ations for
therapy. Can.e& Res, 2., 2+E-F1.
1++. Nire, 0., renner, %., Depl#s, ., lan!hon, )., 9raga, "., Didelot, %., "orey, ).,
Nan 0ynde, A., ernard, D., Nanderinden, J."., ollen, "., 0steller, "., Di
%ro!e, )., de )a#noit, Q. and 9#ks, 9. H2++EI The Poly!om3 gro#p protein 0O2
dire!tly !ontrols D'A methylation. Na%/&e, ,/., F1-C.
1+1. $al-Qam, 0.'., 0gger, $., :nig#e8, )., olster, ., 0inarsson, S., Ohang, ., )in,
J.%., )iang, $., Jones, P.A. and Tanay, A. H2++I 9reB#ent sit!hing of
Poly!om3 repressi(e marks and D'A hypermethylation in the P%; prostate
!an!er !ell line. P&o. Na%) A.ad S.$ U S A, +43, 12F-C.
1+2. "orey, )., renner, %., 9a8i, 9., Nilla, ., $#tierre8, A., #s!h3e!k, "., 'er(i,
%., "in#!!i, S., 9#ks, 9. and Di %ro!e, ). H2++I "D;, a !omponent of the
'#D !omple7, fa!ilitates !hromatin alteration and deposition of epigeneti!
marks. Mo) Ce)) B$o) , -0, 12-2;.
1+;. 9eng, R. and Ohang, Q. H2++1I The "e%P1 !omple7 represses trans!ription
thro#gh preferential 3inding, remodeling, and dea!etylating methylated
n#!leosomes. Genes ev, +3, 2F-;2.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 43/56
C;
1+C. eisman, D., $laros, S. and Thompson, 0.A. H2++I The S<:&S'9 !omple7 and
!an!er. 5n.oene, -0, 1E;-E.
1+. %hai, J., %har3onea#, A.)., et8, .). and <eissman, .0. H2++I )oss of the
hS'9 gene !on!omitantly ina!ti(ates p21%:P&<A91 and p1E:'KCa a!ti(ity
asso!iated ith repli!ati(e senes!en!e in A2+C rha3doid t#mor !ells. Can.e& Res,
23, 1+12-.
1+E. eisman, D.'., S!iarrotta, J., <ang, <., 9#nkho#ser, <.K. and <eissman, .0.
H2++;I )oss of $1&" in h#man l#ng !an!er !ell lines and primary l#ng
!an!ers/ !orrelation ith poor prognosis. Can.e& Res, 2/, E+-E.
1+F. 'aid#, S.., )o(e, :."., :m3al8ano, A.'., $rossman, S.. and Androphy, 0.J.
H2++I The S<:&S'9 !hromatin remodeling s#3#nit $1 is a !riti!al reg#lator
of p; ne!essary for proliferation of malignant !ells. 5n.oene, -0, 2C2-+1.
1+. <it!her, ". and 0merson, .". H2++I 0pigeneti! silen!ing of the p1EH:'KCaI
t#mor s#ppressor is asso!iated ith loss of %T%9 3inding and a !hromatin
3o#ndary. Mo) Ce)) , /,, 2F1-C.
1+. )#, J., $et8, $., "iska, 0.A., Al(are8-Saa(edra, 0., )am3, J., Pe!k, D., Seet-
%ordero, A., 03ert, .)., "ak, .., 9errando, A.A., Doning, J.., Ja!ks, T.,
or(it8, .. and $ol#3, T.. H2++I "i!ro'A e7pression profiles !lassify
h#man !an!ers. Na%/&e, ,/3, ;C-.
11+. Nent#ra, A. and Ja!ks, T. H2++I "i!ro'As and !an!er/ short 'As go a long
ay. Ce)) , +/2, E-1.
111. Saito, Q., )iang, $., 0gger, $., 9riedman, J."., %h#ang, J.%., %oet8ee, $.A. and
Jones, P.A. H2++EI Spe!ifi! a!ti(ation of mi!ro'A-12F ith donreg#lation of
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 44/56
CC
the proto-on!ogene %)E 3y !hromatin-modifying dr#gs in h#man !an!er !ells.
Can.e& Ce)) , ., C;-C;.
112. %han, J.A., Kri!he(sky, A.". and Kosik, K.S. H2++I "i!ro'A-21 is an
antiapoptoti! fa!tor in h#man glio3lastoma !ells. Can.e& Res, 23, E+2-;;.
11;. Kl#i(er, J., Kroesen, .J., Poppema, S. and (an den erg, A. H2++EI The role of
mi!ro'As in normal hematopoiesis and hematopoieti! malignan!ies. Le/e($a,
-4, 1;1-E.
11C. Dorsett, Q., "!ride, K."., Janko(i!, "., $a8#myan, A., Thai, T.., o33iani,
D.9., Di Nirgilio, "., San-"artin, .., eidkamp, $., S!hi!kert, T.A.,
0isenrei!h, T., a4esky, K. and '#ssen8eig, ".%. H2++I "i!ro'A-1
s#ppresses a!ti(ation-ind#!ed !ytidine deaminase-mediated "y!-:gh
translo!ation. I((/n$%4, -0, E;+-.
11. "endell, J.T. H2++I miiad roles for the mi-1F-2 !l#ster in de(elopment and
disease. Ce)) , +//, 21F-22.
11E. Deng, S., %alin, $.A., %ro!e, %."., %o#kos, $. and Ohang, ). H2++I
"e!hanisms of mi!ro'A dereg#lation in h#man !an!er. Ce)) C4.)e, 1, 2EC;-E.
11F. )#4am3io, A., %alin, $.A., Nillan#e(a, A., opero, S., San!he8-%espedes, ".,
lan!o, D., "ont#enga, )."., ossi, S., 'i!oloso, ".S., 9aller, <.J., $allagher,
<."., 0!!les, S.A., %ro!e, %.". and 0steller, ". H2++I A mi!ro'A D'A
methylation signat#re for h#man !an!er metastasis. P&o. Na%) A.ad S.$ U S A,
+43, 1;E-E1.
11. Toyota, "., S#8#ki, ., Sasaki, Q., "ar#yama, ., :mai, K., Shinom#ra, Q. and
Tokino, T. H2++I 0pigeneti! silen!ing of mi!ro'A-;C3&! and -!ell
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 45/56
C
translo!ation gene C is asso!iated ith %p$ island methylation in !olore!tal
!an!er. Can.e& Res, 20, C12;-;2.
11. "ats#3ayashi, ., Sato, '., 9#k#shima, '., Qeo, %.J., <alter, K."., r#ne, K.,
Sahin, 9., r#3an, .. and $oggins, ". H2++;I "ethylation of !y!lin D2 is
o3ser(ed freB#ently in pan!reati! !an!er 3#t is also an age-related phenomenon in
gastrointestinal tiss#es. C)$n Can.e& Res, ., 1CCE-2.
12+. Peters, :., Naske, ., Al3re!ht, K., K#!8yk, ".A., Jonas, U. and Serth, J. H2++FI
Adiposity and age are statisti!ally related to enhan!ed ASS91A t#mor
s#ppressor gene promoter methylation in normal a#topsy kidney tiss#e. Can.e&
Ep$de($o) B$o(a&e&s P&ev, +2, 22E-;2.
121. Al-a44, "., <i!ha, ".S., enito-ernande8, A., "orrison, S.J. and %larke, ".9.
H2++;I Prospe!ti(e identifi!ation of t#morigeni! 3reast !an!er !ells. P&o. Na%)
A.ad S.$ U S A, +44, ;;-.
122. S#rani, ".A., ayashi, K. and a4ko(a, P. H2++FI $eneti! and epigeneti!
reg#lators of pl#ripoten!y. Ce)) , +-0, FCF-E2.
12;. Sakatani, T., Kaneda, A., :a!o3#8io-Donah#e, %.A., %arter, ".$., de oom
<it8el, S., Lkano, ., Ko, ".S., Lhlsson, ., )ongo, D.). and 9ein3erg, A.P.
H2++I )oss of imprinting of :gf2 alters intestinal mat#ration and t#morigenesis in
mi!e. S.$en.e, /41, 1FE-.
12C. o!hedlinger, K., lello!h, ., rennan, %., Qamada, Q., Kim, "., %hin, ). and
Jaenis!h, . H2++CI eprogramming of a melanoma genome 3y n#!lear
transplantation. Genes ev, +0, 1F-.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 46/56
CE
12. aylin, S.. and Lhm, J.0. H2++EI 0pigeneti! gene silen!ing in !an!er - a
me!hanism for early on!ogeni! pathay addi!tion Na% Rev Can.e& , 2, 1+F-1E.
12E. <er3oetski-Lgil(ie, T.0., osse, "., Steart, "., S!hner!h, A., amos-"e4ia,
N., o#lea#, A., <ynder, T., Smith, ".J., Dingall, S., %arter, T., <illiams, %.,
arris, %., Dolling, J., <ynder, %., oreham, D. and hatia, ". H2++I
%hara!teri8ation of h#man em3ryoni! stem !ells ith feat#res of neoplasti!
progression. Na% B$o%e.3no) , -1, 1-F.
12F. %onstantinides, P.$., Jones, P.A. and $e(ers, <. H1FFI 9#n!tional striated
m#s!le !ells from non-myo3last pre!#rsors folloing -a8a!ytidine treatment.
Na%/&e, -21, ;EC-E.
12. Plima!k, 0.., Kantar4ian, .". and :ssa, J.P. H2++FI De!ita3ine and its role in
the treatment of hematopoieti! malignan!ies. Le/ L4(p3o(a, ,0, 1CF2-1.
12. %heng, J.%., Qoo, %.., <eisen3erger, D.J., %h#ang, J., <o8niak, %., )iang, $.,
"arB#e8, N.0., $reer, S., Lrntoft, T.9., Thyk4aer, T. and Jones, P.A. H2++CI
Preferential response of !an!er !ells to 8e3#larine. Can.e& Ce)) , 2, 11-.
1;+. Qang, A.S., 0ste!io, ".., $ar!ia-"anero, $., Kantar4ian, .". and :ssa, J.P.
H2++;I %omment on %hromosomal insta3ility and t#mors promoted 3y D'A
hypomethylation and :nd#!tion of t#mors in ni!e 3y genomi!
hypomethylation. S.$en.e, /4-, 11;M a#thor reply 11;.
1;1. %orte8, %.%. and Jones, P.A. H2++I %hromatin, !an!er and dr#g therapies. M/%a%
Res, 2,1, CC-1.
1;2. Datta, J., $hoshal, K., Denny, <.A., $amage, S.A., rooke, D.$., Phiasi(ongsa,
P., edkar, S. and Ja!o3, S.T. H2++I A ne !lass of B#inoline-3ased D'A
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 47/56
CF
hypomethylating agents rea!ti(ates t#mor s#ppressor genes 3y 3lo!king D'A
methyltransferase 1 a!ti(ity and ind#!ing its degradation. Can.e& Res, 2., C2FF-
.
1;;. %are, J.S., $iles, 9.J. and 'aro!ki, S.T. H2++I istone dea!etylase inhi3itors/
me!hanisms of !ell death and promise in !om3ination !an!er therapy. Can.e&
Le%% , -2., F-1F.
1;C. %ameron, 0.0., a!hman, K.0., "yohanen, S., erman, J.$. and aylin, S..
H1I Synergy of demethylation and histone dea!etylase inhi3ition in the re-
e7pression of genes silen!ed in !an!er. Na% Gene% , -+, 1+;-F.
1;. Kliso(i!, ".:., "aghra3y, 0.A., Parth#n, ".., $#imond, "., Sklenar, A..,
<hitman, S.P., %han, K.K., "#rphy, T., Anon, J., Ar!her, K.J., #sh, ).J., Plass,
%., $re(er, ".., yrd, J.%. and "ar!#!!i, $. H2++;I Depsipeptide H9 +122I
promotes histone a!etylation, gene trans!ription, apoptosis and its a!ti(ity is
enhan!ed 3y D'A methyltransferase inhi3itors in A")1&0TL-positi(e le#kemi!
!ells. Le/e($a, +1, ;+-.
1;E. elinsky, S.A., Klinge, D."., Stidley, %.A., :ssa, J.P., erman, J.$., "ar!h, T..
and aylin, S.. H2++;I :nhi3ition of D'A methylation and histone dea!etylation
pre(ents m#rine l#ng !an!er. Can.e& Res, 2/, F+-;.
1;F. Tan, J., Qang, ., Oh#ang, )., Jiang, ., %hen, <., )ee, P.)., Kar#t#ri, .K., Tan,
P.., )i#, 0.T. and Q#, R. H2++FI Pharma!ologi! disr#ption of Poly!om3-
repressi(e !omple7 2-mediated gene repression sele!ti(ely ind#!es apoptosis in
!an!er !ells. Genes ev, -+, 1++-E;.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 48/56
C
1;. "iranda, T.., %orte8, %.%., Qoo, %.., )iang, $., A3e, "., Kelly, T.K.,
"arB#e8, N.0. and Jones, P.A. H2++I DO'ep is a glo3al histone methylation
inhi3itor that rea!ti(ates de(elopmental genes not silen!ed 3y D'A methylation.
Mo) Can.e& !3e& , 0, 1F-.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 49/56
C
TABLE LEGEND
Ta)le I5 Epigenetic %echanis%s in!l!e" in reg$lating gene e6pressin an"
chr%atin str$ct$re in nr%al %a%%alian cells5 0pigeneti! me!hanisms in!l#ding
D'A methylation, !o(alent histone modifi!ations, n#!leososme positioning and
mi!ro'As are essential for normal mammalian de(elopment and reg#lation of gene
e7pression. These epigeneti! modifi!ations display #niB#e properties and distri3#tion
patterns in different mammalian !ells. The distin!t !om3inatorial patterns of these
modifi!ations, !olle!ti(ely termed the epigenome, are key determinants of !ell fate and
gene a!ti(ity. 0m3ryoni! stem !ells maintain a more plasti! epigenome reB#ired for
de(elopmental pro!esses. :n !ontrast, the epigenome of differentiated tiss#e displays a
relati(ely restri!ted str#!t#re hi!h is sta3ly maintained thro#gh m#ltiple !ell di(isions.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 50/56
+
(IGURE LEGENDS
(ig5 +5 Epigenetic gene silencing %echanis%s in %a%%als5 HAI An a!ti(e gene shos
an open !hromatin str#!t#re !onsisting of an #nmethylated promoter region Hsmall hite
!ir!les on D'A strandsI, ith no n#!leosome #pstream of the trans!ription start site
HTSS, thi!k 3la!k arroI, an enri!hment of a!ti(e histone marks s#!h as a!etylation
Hgreen triangle, A!I and ;KC methylation Hgreen !ir!les, CI and high le(els of 2A.O on
n#!leosomes HorangeI s#rro#nding the TSS. The open !hromatin str#!t#re is permissi3le
for 3inding of trans!ription fa!tors and 'A Pol-::, hi!h mediate a!ti(e trans!ription
on s#!h promoters. epression of s#!h a!ti(e genes Hindi!ated 3y red arrosI !an 3e
a!hie(ed in normal !ells 3y to main me!hanisms/ HI $ene repression 3y the a!tion of
Poly!om3 epressi(e $ro#p HP%1 and P%2I hi!h mediate the repressi(e ;K2F
methylation Hred !ir!les, 2FI, is a!!ompanied 3y the remo(al of a!etylation 3y histone
dea!etylases, loss of ;KC methylation, !hromatin !ompa!tion and n#!leosome
o!!#pan!y in the '9 and #3iB#itylation of 2A.OM H%I )ong-term silen!ing thro#gh
D'A methylation is performed 3y D'A methyltransferases. D'A methylation Hsmall red
!ir!les on D'A strandsI is often a!!ompanied 3y the repressi(e ;K methylation Hred
!ir!les, I, on promoters, hi!h leads to !hromatin !ompa!tion 3y re!r#itment of P1.
D'A "ethylated silen!ed promoters sho a depletion of 2A.O, loss of ;KC
methylation and histone de-a!etylation. A!/ a!etylation, U3/ #3iB#itination, KC-"T/
istone ; lysine C histone methyltransferase, K-"T/ istone ; lysine histone
methyltransferase, AT/ histone a!etyltransferase, DA%/ histone dea!etylase, P%1
and P%2/ poly!om3 repressi(e !omple7 1 and 2, 0O2/ enhan!er of 8este homolog#e 2,
P1/ hetero!hromatin protein 1, Pol-::/ 'A polymerase ::.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 51/56
1
(ig5 -5 DNA %ethylatin changes in cancer5 :n normal !ells, %p$ island promoters are
generally #nmethylated and hen a!ti(e, as in the !ase of t#mor s#ppressor genes, are
a!!ompanied 3y a!ti(e histone marks s#!h as a!etylation and ;KC methylation Hgreen
!ir!les, CI alloing for a trans!riptionally a!ti(e open !hromatin str#!t#re. oe(er,
repetiti(e regions, transposons, %p$ poor intergeni! regions and imprinted gene
promoters are hea(ily methylated and a!!ompanied 3y repressi(e histone marks s#!h as
;K methylation Hred !ir!les, I hi!h together form a silent !hromatin state. D#ring
t#morigenesis, t#mor s#ppressor gene promoters ith %p$ islands 3e!ome methylated,
res#lting in the formation of silent !hromatin str#!t#re and a3errant silen!ing Hindi!ated
3y the red arroI. :n !ontrast, the repetiti(e seB#en!es, transposons and imprinted gene
promoters 3e!ome hypomethylated res#lting in a3errant a!ti(ation Hindi!ated 3y the
green arroI.
(ig5 /5 Reprgra%%ing # the epigen%e "$ring "e!elp%ent an" t$%rigenesis.
HAI :n em3ryoni! stem !ells, de(elopmentally important genes are marked 3y a #niB#e
=3i(alent domain> str#!t#re, !onsisting of the a!ti(e ;KC methylation Hgreen !ir!les, CI
and repressi(e ;K2F methylation Hred !ir!les, 2FI marks together ith 2A.O. S#!h
3i(alent domains are important for maintaining epigenomi! plasti!ity that is reB#ired
d#ring de(elopment. D#ring differentiation, the =3i(alent domains> are lost, gi(ing ay
to the esta3lishment of a more rigid =mono(alent domain> str#!t#re hi!h is either a!ti(e
Hindi!ated 3y the green arroI or repressi(e Hindi!ated 3y the red arroI depending #pon
hi!h mark is maintained. HI :n !an!er, !ells #ndergo a3errant somati! reprogramming
hi!h res#lts in gene silen!ing thro#gh formation of a !ompa!t !hromatin str#!t#re.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 52/56
2
Silen!ing !an o!!#r thro#gh P% HPoly!om3 epressi(e %omple7I reprogramming V
silen!ing of a!ti(e genes 3y the poly!om3 gro#pM D'A methylation reprogramming V
silen!ing thro#gh de novo hypermethylation Hsmall red !ir!les on D'A strandsI
a!!ompanied 3y ;K methylation Hred !ir!les, IM or epigeneti! sit!hing V
repla!ement of gene repression 3y the poly!om3 mark ith long-term silen!ing thro#gh
D'A methylation. U3/ #3iB#itylation.
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 53/56
DNA
Methylation
All Cell Types
- Stable Heritable Modification- Gene Silencing- Chromatin Organization- Imprinting, X-Chromosome Inactivation, Silencing of
Repetitive lements- Mediated b! "#M$s
ES Cells
- %imodal "istrib&tion 'attern
Global CpG Meth!lation
CpG Islands (nmeth!lated
- 'l&ripotenc! Gene 'romoters (nmeth!lated
Somatic Cells
- $iss&e Specific Meth!lation of some CpG Islands and mostnon-CpG Island 'romoters
- 'l&ripotenc! Gene 'romoters Meth!lated
Covalent
Histone
Modifications
All Cell Types
- )abile Heritable Modification- %oth Gene Silencing *H+me, H+./me etc01 2 Gene
3ctivation *H+4me, 3cet!lation etc01- Specific "istrib&tion 'atterns of Histone Mar5s contrib&te to
Chromatin Organization- Mediated b! HM$s, H"Ms, H3$s 2 H"3Cs etc0
ES Cells
- %ivalent "omains - Coe6istence of 3ctive and Repressive
Mar5s *H+4me 2 H+./me1 at promoters of developmentall!
important genes
- 'lastic pigenome
Somatic Cells
- )oss of %ivalenc! and Restricted pigenome- stablishment of $iss&e Specific Monovalent H+./me and
H+4me "omains- 'resence of )arge Organized Chromatin Modifications
*)OCs1
Nucleosome
Positioning
& Histone
a!iants
All Cell Types
- )abile pigenetic Reg&lator! Mechanism- %oth Gene Silencing and Gene 3ctivation b! mod&lating
chromatin accessibilit!- Mediated b! 3$' dependent Chromatin Remodeling
Comple6es- %oth sliding of e6isting and incorporation of ne7 n&cleosomes
- H.308 and H+0+ preferentiall! localized to gene promoters7hich are active or poised for activation
- 3cet!lated H.308 associates 7ith &chromatin and
&bi9&it!lated H.308 7ith :ac<ative Heterochromatin
mic!o"NAsAll Cell Types
- )abile pigenetic Reg&lator! Mechanism
- Gene Silencing- $iss&e-specific e6pression- Can be pigeneticall! Reg&lated
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 54/56
8/13/2019 Epigenetics in Cancer Carcinogenesis 2009
http://slidepdf.com/reader/full/epigenetics-in-cancer-carcinogenesis-2009 55/56